Antibody Bank
(Kato's Lab; Tohoku University)

--> company (clone)
--> Kato' lab in Tohoku University Graduate School of Medicine



Peptide tag system
PA tag
NZ-1
CharacterApplicationRefGene cloningCompany
anti-PA tag mAb
NZ-1; rat IgG2a, lambda
PAtag: GVAMPGAEDDVV; 12 amino acid; trademark: No. 5671624; ref: Nature; Communications biology Purification, IP, IHC, WB, FACS PEP2014; JCS2016
PS2019; AC2021
Sci2022
done Wako
anti-PA tag mAb
NZ-27; human IgG1, lambda
PAtag: GVAMPGAEDDVV; 12 amino acid; trademark: No. 5671624; from AMED_PDIS project Purification, IP, IHC, WB, FACS JBC2023 done
anti-PA14 tag mAb
NZ-1; rat IgG2a, lambda
PA14 tag: EGGVAMPGAEDDVV; from AMED_SentanBio Purification, IP, IHC, WB, FACS PA14 tag system
hGH-fusion Fab
done
anti-PA16 tag mAb
NZ-1; rat IgG2a, lambda
PA16 tag: GLEGGVAMPGAEDDVV; from AMED_SentanBio Purification, IP, IHC, WB, FACS C44Mab5; PMab202; PMab210; PMab213; PMab219; PMab233 done
MAP tag
PMab-1
CharacterApplicationRefGene cloningCompany
anti-MAP tag mAb
PMab-1: rat IgG2a, kappa--> PAtag
MAPtag (GDGMVPPGIEDK; 12 amino acids); trademark: No. 5988384; from AMED_KakushinBio; press release Purification, IP, IHC, WB, FACS MAB2016
BBREP2018
JB2020
done AA; abcam; Nov; Merck; BioLegend
anti-MAP16 tag mAb
(PMab-1; rat IgG2a, kappa)
MAP16 tag: PGTGDGMVPPGIEDKI; 16 amino acids; from AMED_Tousa Purification, IP, IHC, WB, FACS PMab-235
PMab-44_goat
done
RAP tag
PMab-2
CharacterApplicationRefGene cloningCompany
anti-RAP tag mAb
(PMab-2; mouse IgG1, kappa)--> PAtag
RAP tag: DMVNPGLEDRIE; 12 amino acids; from AMED_KakushinBio Purification, IP, IHC, WB, FACS MAB2017
FPS2020
PP2021
done AA; abcam
Merck; BioLegend
anti-RAP14 tag mAb (double tag)
(PMab-2; LpMab-7)
RAP14 tag (DMVNPGLEDRIEDL; 14 amino acids); from AMED_Tousa Purification, IP, IHC, WB, FACS PMab44; PMab256; PDF; PMab253 done
anti-RAP16 tag mAb
(PMab-2; mouse IgG1, kappa)
RAP16 (GPGDDMVNPGLEDRIE; 16 amino acids); from AMED_SentanBio Purification, IP, IHC, WB, FACS PMab-225_alpaca
PMab-225_epitope
PMab-44_alpaca
done
RIEDL tag
LpMab-7
CharacterApplicationRefGene cloningCompany
anti-RIEDL tagmAb
(LpMab-7; mouse IgG1, kappa)-->PAtag
RIEDLtag (RIEDL; 5 amino acids): from AMED_SentanBio Purification, IP, IHC, WB, FACS RIEDL; PMab237 (1); PMab237 (2); C44-5; C44-46; E134; E51 done abcam
MBP tag
TMab-2
CharacterApplicationRefGene cloningCompany
anti-MBP tag mAb
(TMab-2; rat IgG2b, kappa)
specific for maltose-binding protein IHC, WB PubMed
done
anti-MBP tag mAb
(YM-2;rat IgG2b, kappa)
specific for maltose-binding protein IHC, WB PubMed
done BioLegend
BAP tag
PMab-44
CharacterApplicationRefGene cloningCompany
anti-BAP tagmAb
(PMab-44; mouse IgG1, kappa)--> PAtag
BAP tag(EKTTLGVEDYTTTPAA; 16 amino acids); from AMED_BINDS_SentanBio Purification, IP, IHC, WB, FACS PMab247
PMab241
done Zenogen
LP tag
LpMab-17
CharacterApplicationRefGene cloningCompany
anti-LP tag mAb
(LpMab-17; mouse IgG1, kappa)-->PAtag
LPtag (NSVTGIRIEDLPTSES; 16 amino acids); from AMED_BINDS_SentanBio Purification, IP, IHC, WB, FACS PMab52
PMab231
done BD
Merck
His tag
HisMab-1
CharacterApplicationRefGene cloningCompany
anti-His tag (HisMab-1;mouse IgG2b, kappa)-->PAtag His tag (HHHH; 4 amino acids); from AMED_SentanBio; Kd: 4.4 x 10^-9 M Purification, IP, IHC, WB, FACS C20Mab60
Rituximab
C20Mab11
done
anti-His tag (HisMab-1-hG1; human IgG1, kappa) His tag (HHHH; 4 amino acids); from AMED_SentanBio Purification, IP, IHC, WB, FACS done
anti-His tag (HisMab-1-scFv-mG2a; mouse IgG2a) scFv of HisMab-1; Kd: 6.6 x 10^-9 M IHC, WB, FACS done
Back to list



Isotype control
antibody
(mouse)
CharacterApplicationRefGene cloningCompany
anti-SARS-CoV-2 mAb (CvMab-62; mouse IgG1, kappa) specific for SARS-CoV-2 S2 ELISA
isotype control
of mouse IgG1
CvMab-62 done
anti-tiger PDPN mAb (PMab-231-f; mouse IgG2a, kappa) defucosylation of PMab-231 isotype control of
mouse IgG2a in vivo
250_in vivo done zenogen
anti-hamPDPN mAb (281-mG2a-f; mouse IgG2a, kappa) defucocylated 281-mG2a isotype control of
mouse IgG2a in vivo
H2Mab-214
H2Mab-77
done
anti-RdRP mAb (RdMab-20; mouse IgG2b, kappa) specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP ELISA, WB
isotype control
of mouse IgG2b
RdMab-20
anti-RdRP mAb (RdMab-13; mouse IgM, kappa) specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP ELISA, WB
isotype control
of mouse IgM
RdMab-13
antibody
(rat)
CharacterApplicationRefGene cloningCompany
anti-mTERT mAb (TmMab-1; rat IgG1, kappa) specific for mTERT ELISA, WB
isotype control
of rat IgG1
done
anti-mTERT mAb (TmMab-2; rat IgG2a, kappa) specific for mTERT ELISA
isotype control
of rat IgG2a
done
anti-IDH1 mAb(RcMab-1; rat IgG2a, kappa) specific for IDH1 IHC, WB
isotype control of rat IgG2a
RcMab-1 abcam
CST
MBL
anti-IDH2-R172K mAb (KMab-1; rat IgG2b, kappa) specific for IDH2-R172K IHC, WB
isotype control of rat IgG2b
KMab-1 done abcam
MBL
antibody
(human)
CharacterApplicationRefGene cloningCompany
anti-SARS-CoV-2 mAb (humCvMab-62; human IgG1, kappa) specific for SARS-CoV-2 S2 ELISA
isotype control
of human IgG1
done
Back to list



Chemokine receptor (summary)
mouse CCR1
(
CD191)
Character
--> anti-human CCR1
ApplicationRefGene cloningCompany
anti-mouse CCR1 mAb (C1Mab-1; rat IgG2b, lambda) CBIS method; Kd: 1.5 x 10^-8 M
ref: clone S15040E (BioLegend); rat IgG2b; Kd: 3.5 x 10^-8 M; no mAb from BD (summary)
FACS, WB
anti-mouse CCR1 mAb (C1Mab-2; rat IgG2b, lambda) CBIS method
Kd: 3.9 x 10^-9 M
FACS, WB
anti-mouse CCR1 mAb (C1Mab-5; rat IgG2b, lambda) CBIS method
Kd: 1.2 x 10^-8 M
FACS, WB
anti-mouse CCR1 mAb (C1Mab-6; rat IgG2b, kappa) CBIS method
Kd: 3.9 x 10^-9 M
FACS, WB C1Mab-6 done
Back to list

mouse CCR2
(
CD192)
Character
--> anti-human CCR2
ApplicationRefGene cloningCompany
anti-mouse CCR2 mAb (C2Mab-6; rat IgG1, kappa) ref: clone EPR20844-15 (abcam); rabbit IgG
ref: clone 475301 (BD); rat IgG2b
ref: clone SA203G11 (BioLegend); rat IgG2b
FACS, WB, ICC C2Mab-6
epitope
(summary)
done BD
Back to list

mouse CCR3
(
CD193)
Character
--> anti-human CCR3
ApplicationRefGene cloningCompany
anti-mouse CCR3 mAb(C3Mab-2; rat IgG2b, kappa)
specific for mouse CCR3; established by CBIS method (summary) FACS C3Mab-2
ICC
done
anti-mouse CCR3 mAb (C3Mab-3; rat IgG2a, kappa0 specifc mouse CCR3; established by CBIS method FACS C3Mab-3
epitope
done
anti-mouse CCR3 mAb (C3Mab-4; rat IgG2a, kappa) specific mouse CCR3; established by CBIS method FACS epitope done
anti-mouse CCR3 mAb (C3Mab-6; rat IgG1, kappa) specific mouse CCR3; peptide immunization FACS C3Mab-6
epitope
done
anti-mouse CCR3 mAb (C3Mab-7; rat IgG1, kappa) specific mouse CCR3; peptide immunization FACS C3Mab-7
epitope-1
epitope-2
done
Back to list

mouse CCR4
(
CD194)
CharacterApplicationRefGene cloningCompany
anti-mouse CCR4 mAb (C4Mab-1; rat IgG1, kappa) specific for mouse CCR4; peptide immunization
2G12 (BioLegend); hamster IgG
no mAb from BD (summary)
FACS C4Mab-1
epitope
done
anti-mouse CCR4 mAb (C4Mab-1-mG2a-f; mIgG2a,k) specific for mouse CCR4 FACS done
Back to list

mouse CCR5
(
CD195)
CharacterApplicationRefGene cloningCompany
anti-mouse CCR5 mAb (C5Mab-1; rat IgM, kappa) specific for CCR5 (by CBIS method) ; ref: clone C34-3448 (BD); rat IgG2c; ref: clone HM-CCR5 (BioLegend); hamster (Kd: 1.6 x 10^-7) (summary) FACS done
anti-mouse CCR5 mAb (C5Mab-2; rat IgG2b, kappa) specific for CCR5
by CBIS method
(Kd: 4.3 x 10^-8)
FACS C5Mab-2 done
anti-mouse CCR5 mAb (C5Mab-3; rat IgG2b, kappa) specific for CCR5
by CBIS method
(Kd: 5.8 x 10^-8)
FACS done
anti-mouse CCR5 mAb (C5Mab-4; rat IgG2a, kappa) specific for CCR5
by peptide immunization (Kd: 3.5 x 10^-8)
immunogen: MDFQGSVPTYSYDIDYGMS
FACS, WB C5Mab-4 done
anti-mouse CCR5 mAb (C5Mab-5; rat IgG2a, kappa) specific for CCR5
by peptide immunization (Kd: 8.1 x 10^-8)
immunogen: MDFQGSVPTYSYDIDYGMS
FACS, WB done
anti-mouse CCR5 mAb (C5Mab-7; rat IgG1, kappa) specific for CCR5
by peptide immunization
immunogen: MDFQGSVPTYSYDIDYGMS
FACS done
anti-mouse CCR5 mAb (C5Mab-8; rat IgG1, kappa) specific for CCR5
by peptide immunization (Kd: 7.3 x 10^-9)
immunogen: MDFQGSVPTYSYDIDYGMS
FACS, WB C5Mab-8 done
Back to list

mouse CCR6
(
CD196)
Character
--> anti-human CCR6
ApplicationRefGene cloningCompany
anti-mouse CCR6 mAb (C6Mab-9; rat IgG1, kappa) peptide immunization
immunogen: MNSTESYFGTDDYDNTEYY
(summary)
FACS done
anti-mouse CCR6 mAb (C6Mab-9-mG2a-f; mIgG2a,k) mouse IgG2a type of C6Mab-9
ref: clone 29-2L17 (BioLegend); hamster IgG
ref: clone 140706 (BD); rat IgG2a
FACS done
anti-mouse CCR6 mAb (C6Mab-10; rat IgG2a, kappa) peptide immunization
immunogen: MNSTESYFGTDDYDNTEYY
FACS, WB done
anti-mouse CCR6 mAb (C6Mab-13; rat IgG1, kappa) peptide immunization
immunogen: MNSTESYFGTDDYDNTEYY
FACS C6Mab-13
epitope
done
Back to list

mouse CCR7
(
CD197)
CharacterApplicationRefGene cloningCompany
anti-mouse CCR7 mAb (C7Mab-2, rat IgG2b, kappa) specific for mouse CCR7; ref: clone: 4B12 (Biolegend) FACS in preparation (Satofuka et al)
anti-mouse CCR7 mAb (C7Mab-4, rat IgG2a, kappa) specific for mouse CCR7 FACS
Back to list

mouse CCR8
(
CD198)
Character
--> anti-human CCR8
ApplicationRefGene cloningCompany
anti-mouse CCR8 mAb (C8Mab-1;
rat IgG2a, kappa)
clone SA214G2 (BioLegend); rat IgG2b
no mAb from BD
patent (Shionogi/Osaka Univ.) (summary)
FACS, ICC C8Mab-1 done
anti-mouse CCR8 mAb (C8Mab-2;
rat IgG2b, kappa)
specific mouse CCR8
established by CBIS method
FACS, ICC C8Mab-2
ICC
epitope
done Merck
anti-mouse CCR8 mAb (C8Mab-2-mG2a) mouse IgG2a type of C8Mab-2
established by CBIS method
FACS, ICC done
anti-mouse CCR8 mAb (C8Mab-3;
rat IgG1, kappa)
specific mouse CCR8
established by CBIS method
FACS, ICC C8Mab-3 done
Back to list

mouse CCR9
(
CD199)
Character
--> anti-human CCR9
ApplicationRefGene cloningCompany
anti-mouse CCR9 mAb (C9Mab-24; rat IgG2a, kappa) immunogen: MMPTELTSLIPGMFDDFSYC (summary)
ref: clone 9B1 (
BioLegend; BD); rat IgG2a
ref: clone CW-1.2 (BioLegend; BD); mouse IgG2a
FACS, WB C9Mab-24
epitope
done
Back to list

mouse CCR10
CharacterApplicationRefGene cloningCompany
anti-mouse CCR10 mAb (CC10Mab-1; rat IgM, kappa) CBIS method
(summary)
ref: clone 248918R (R&D); rat IgG2a
FACS in preparation
(Li et al)
Back to list

mouse CXCR1
(
CD181)
CharacterApplicationRefGene cloningCompany
anti-mouse CXCR1 mAb (Cx1Mab-1; rat IgG1, kappa) by CBIS; Kd: 2.6 x 10^-9 M (summary)
ref: clone 1122A (R&D); rabbit IgG; Kd: 2.7 x 10^-9 M; clone U45-632 (BD); rat IgG2b
FACS, WB Cx1Mab-1 done
anti-mouse CXCR1 mAb (Cx1Mab-2; rat IgG1, kappa) Kd: 2.0 x 10^-9 M
immunogen: MAEAEYFIWTNPEGDFEKE
FACS
WB (weak)
anti-mouse CXCR1 mAb (Cx1Mab-3; rat IgG2a, kappa) Kd: 6.2 x 10^-10 M
immunogen: MAEAEYFIWTNPEGDFEKE
FACS
WB (weak)
anti-mouse CXCR1 mAb (Cx1Mab-4; rat IgG1, kappa) Kd: 2.1 x 10^-9 M
immunogen: MAEAEYFIWTNPEGDFEKE
FACS
anti-mouse CXCR1 mAb (Cx1Mab-5; rat IgG2a, kappa) Kd: 8.2 x 10^-9 M
immunogen: MAEAEYFIWTNPEGDFEKE
FACS, WB
anti-mouse CXCR1 mAb (Cx1Mab-6; rat IgG1, kappa) Kd: 1.0 x 10^-9 M
immunogen: MAEAEYFIWTNPEGDFEKE
FACS
anti-mouse CXCR1 mAb (Cx1Mab-7; rat Ig2b, kappa) Kd: 8.1 x 10^-9 M
immunogen: MAEAEYFIWTNPEGDFEKE
FACS
anti-mouse CXCR1 mAb (Cx1Mab-8; rat Ig2b, kappa) Kd: 3.0 x 10^-10 M
immunogen: MAEAEYFIWTNPEGDFEKE
FACS in preparation (Li G et al)
Back to list

mouse CXCR2
(
CD182)
CharacterApplicationRefGene cloningCompany
anti-mouse CXCR2 mAb (Cx2Mab-1; rat IgG2b, kappa) immunogen: MGEFKVDKFNIEDFFSGDL; Kd: 9.4 x 10^-9 M; ref: SA045E1 (BioLegend; Kd: 1.6 x 10^-8 M) FACS in preparation (Kaneko et al) done
anti-mouse CXCR2 mAb (Cx2Mab-2; rat IgG2b, kappa) immunogen: MGEFKVDKFNIEDFFSGDL
Kd: 1.0 x 10^-8 M (summary)
FACS done
anti-mouse CXCR2 mAb (Cx2Mab-3; rat Ig) specific for mouse CXCR2; by CBIS method FACS in preparation (Kobayashi et al)
anti-mouse CXCR2 mAb (Cx2Mab-4; rat Ig) specific for mouse CXCR2; by CBIS method FACS
Back to list

mouse CXCR3
(
CD183)
CharacterApplicationRefGene cloningCompany
anti-mouse CXCR3 mAb (Cx3Mab-2; rat IgG2b, kappa) immunogen: MYLEVSERQVLDASDFAFL (summary)
Kd: 5.9 x 10^-9 M; ref: clone: CXCR3-173 (BD; BioLegend); hamster IgG; Kd: 1.3 x 10^-9 M
FACS done
anti-mouse CXCR3 mAb (Cx3Mab-4; rat IgG1, kappa) immunogen: MYLEVSERQVLDASDFAFL
Kd: 1.3 x 10^-9 M
FACS Cx3Mab-4 done
anti-mouse CXCR3 mAb (Cx3Mab-5; rat IgG2c, kappa) immunogen: MYLEVSERQVLDASDFAFL
Kd: 5.3 x 10^-9 M
FACS done
anti-mouse CXCR3 mAb (Cx3Mab-6; rat IgG2b, kappa) immunogen: MYLEVSERQVLDASDFAFL
Kd: 4.5 x 10^-9 M
FACS done
Back to list

mouse CXCR4
(
CD184)
CharacterApplicationRefGene cloningCompany
anti-mouse CXCR4 mAb (Cx4Mab-1; rat IgG2a, kappa) by CBIS method; Kd: 6.4 x 10^-9 M; ref: clone 2B11/CXCR4 (BD), rat IgG2b; ref: clone L276F12 (BioLegend), rat IgG2b (summary)
FACS Cx4Mab-1 done
anti-mouse CXCR4 mAb (Cx4Mab-2; rat IgG2b, kappa) specific for mouse CXCR4
immunogen: MEPISVSIYTSDNYSEEVG
FACS, WB in preparation (Yamamoto et al)
anti-mouse CXCR4 mAb (Cx4Mab-3; rat IgG2b, kappa) specific for mouse CXCR4
immunogen: MEPISVSIYTSDNYSEEVG
FACS
anti-mouse CXCR4 mAb (Cx4Mab-4; rat IgG2b, kappa) specific for mouse CXCR4
immunogen: MEPISVSIYTSDNYSEEVG
FACS, WB
anti-mouse CXCR4 mAb (Cx4Mab-5; rat IgG2b, kappa) specific for mouse CXCR4
immunogen: MEPISVSIYTSDNYSEEVG
FACS
Back to list

mouse CXCR5
(
CD185)
CharacterApplicationRefGene cloningCompany
anti-mouse CXCR5 mAb (Cx5Mab-2; rat IgG2a, kappa) immunogen: MNYPLTLDMGSITYNMDDL
Kd: 7.0 x 10^-9; ref: clone 2G8 (BD) ; ref: clone L138D7 (BioLegend) (summary)
FACS
anti-mouse CXCR5 mAb (Cx5Mab-3; IgG2b, kappa) specific for mouse CXCR5; immunogen: MNYPLTLDMGSITYNMDDL
Kd: 7.2 x 10^-10
FACS submit (Ishikawa et al)
anti-mouse CXCR5 mAb (Cx5Mab-4; IgM, kappa) specific for mouse CXCR5; immunogen: MNYPLTLDMGSITYNMDDL
FACS
Back to list

mouse CXCR6
(
CD186)
CharacterApplicationRefGene cloningCompany
anti-mouse CXCR6 mAb(Cx6Mab-1; rat IgG1, kappa) specific for mouse CXCR6; immunogen: MDDGHQESALYDGHYEGDF
(summary)
FACS, WB Cx6Mab-1
epitope-1
epitope-2
done
anti-mouse CXCR6 mAb(Cx6Mab-5; rat IgG1, kappa) specific for mouse CXCR6; immunogen: MDDGHQESALYDGHYEGDF FACS, WB done
Back to list

mouse CX3CR1CharacterApplicationRefGene cloningCompany
anti-mouse CX3CR1 mAb (X3Mab-1; rat IgG1, kappa) immunogen: MSTSFPELDLENFEYDDSA
ref: clone SA011F11 (BioLgend): mouse IgG2a; ref: clone Z8-50 (BD): rat IgG2a
FACS (weak), WB (weak)
anti-mouse CX3CR1 mAb (X3Mab-2; rat IgG1, kappa) specific for mouse CX3CR1
immunogen: MSTSFPELDLENFEYDDSA
FACS (weak), WB (weak)
Back to list

mouse ACKR1CharacterApplicationRefGene cloningCompany
anti-mouse ACKR1 mAb (A1Mab series) specific for ACKR1
ref
FACS
Back to list

mouse ACKR2CharacterApplicationRefGene cloningCompany
anti-mouse ACKR2 mAb (A2Mab series) specific for ACKR2 FACS
Back to list

mouse ACKR3
(CD187, CXCR7)
CharacterApplicationRefGene cloningCompany
anti-mouse ACKR3 mAb (A3Mab-1; rat IgG2a, kappa) specific for mouse ACKR3; immunogen: MDVHLFDYAEPGNYSDINW; ref: 8F11-M1 (BioLegend; Kd: 8.3 x 10^-8 M) FACS
(summary)
in preparation (Yamamoto et al) done
anti-mouse ACKR3 mAb (A3Mab-2; rat IgG2a, kappa) specific for mouse ACKR3; Kd: 1.5 x 10^-8 M FACS, WB
anti-mouse ACKR3 mAb (A3Mab-3; rat IgG2a, kappa) specific for mouse ACKR3; Kd: 2.0 x 10^-8 M FACS, WB
anti-mouse ACKR3 mAb (A3Mab-4; rat IgG2a, kappa specific for mouse ACKR3 FACS
anti-mouse ACKR3 mAb (A3Mab-5; rat IgG2a, kappa) specific for mouse ACKR3; Kd: 2.6 x 10^-9 M FACS
anti-mouse ACKR3 mAb (A3Mab-6; rat IgG2a, kappa) specific for mouse ACKR3; Kd: 1.9 x 10^-8 M FACS, WB
anti-mouse ACKR3 mAb (A3Mab-7; rat IgG2a, kappa) specific for mouse ACKR3 FACS, WB
anti-mouse ACKR3 mAb (A3Mab-8; rat IgG2a, kappa) specific for mouse ACKR3 FACS
Back to list

mouse ACKR4
(CCR11, CCRL1)
CharacterApplicationRefGene cloningCompany
anti-mouse ACKR4 mAb (A4Mab-1; rat IgG2b, kappa) immunogen: MALELNQSAEYYYEENEMN; Kd: 3.5 x 10^-9
no commercially available mAb
FACS, WB(weak) in preparation
(Hirose et al)
anti-mouse ACKR4 mAb (A4Mab-2; rat IgG2b, kappa) immunogen: MALELNQSAEYYYEENEMN
Kd: 6.1 x 10^-9
FACS, WB
anti-mouse ACKR4 mAb (A4Mab-3; rat IgG2b, kappa) immunogen: MALELNQSAEYYYEENEMN
Kd: 1.6 x 10^-9
FACS
Back to list

mouse ACKR5CharacterApplicationRefGene cloningCompany
anti-mouse ACKR5 mAb (A5Mab series) also known as CCRL2
ref: clone S21013E (BioLegend)
FACS
Back to list

mouse XCR1
CharacterApplicationRefGene cloningCompany
anti-mXCR1 mAb in preparation FACS
Back to list

human CCR1CharacterApplicationRefGene cloningCompany
anti-hCCR1 mAb
in preparation
Back to list

human CCR2
(CD192)
Character
--> anti-mouse CCR2
ApplicationRefGene cloningCompany
anti-hCCR2 mAb (C2Mab-9; mouse IgG1, kappa)
specific for human CCR2; expressed in U937 or NK cell; peptide immunization FACS, ICC C2Mab-9
epitope
done
Back to list

human CCR3
Character
--> anti-mouse CCR3
ApplicationRefGene cloningCompany
anti-hCCR3 mAb (C3Mab-8; mouse IgG1, kappa)
specific for human CCR3
peptide immunization; Kd: 5.0 x 10^-9 M
ref: 5E8 (BioLegend); Kd: 2.5 x 10^-9 M
FACS, WB done
Back to list

human CCR4CharacterApplicationRefGene cloningCompany
anti-hCCR4 mAb
in preparation
Back to list

human CCR5CharacterApplicationRefGene cloningCompany
anti-hCCR5 mAb
in preparation
Back to list

human CCR6
(CD196)
Character
--> anti-mouse CCR6
ApplicationRefGene cloningCompany
anti-hCCR6 mAb (C6Mab-19; mouse IgG1, kappa) specific for human CCR6; expressed in HepG2 or HuH-7; peptide immunization
FACS, IHC, ELISA C6Mab-19
Back to list

human CCR7CharacterApplicationRefGene cloningCompany
anti-hCCR7 mAb
in preparation
Back to list

human CCR8Character
--> anti-mouse CCR8
ApplicationRefGene cloningCompany
anti-hCCR8 mAb (C8Mab-20; mouse IgG1, kappa)
specific for human CCR8; peptide immunization; Kd: 3.2 x 10^-7 M; ref: S19017D, L263G8 (BioLegend); 433H (BD) FACS done
anti-hCCR8 mAb (C8Mab-21; mouse IgM, kappa) specific for human CCR8
CBIS method
Kd: 6.5 x 10^-8 M
FACS C8Mab-21 done
Back to list

human CCR9
(CD199)
Character
--> anti-mouse CCR9
ApplicationRefGene cloningCompany
anti-hCCR9 mAb (C9Mab-1; mouse IgG1, kappa) specific for human CCR9; developmed by CBIS method; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS C9Mab-1; epitope
ICC
done BD; exbio
anti-hCCR9 mAb (C9Mab-6; mouse IgG1, kappa) specific for human CCR9; established by CBIS method; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-8; mouse IgG3, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-9; mouse IgG3, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-10; mouse IgG3, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-11; mouse IgG2a, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS, WB C9Mab-11
epitope
done
anti-hCCR9 mAb (C9Mab-12; mouse IgG1, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-13; mouse IgG2a, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-14; mouse IgG1, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-1016;
mouse IgG1, kappa)
specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-17; mouse IgG2b, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-18; mouse IgG3, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-1019;
mouse IgG1, kappa)
specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
anti-hCCR9 mAb (C9Mab-21; mouse IgG3, kappa) specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia) FACS done
Back to list

human CCR10CharacterApplicationRefGene cloningCompany
anti-hCCR10 mAb
in preparation
Back to list

human CCR11CharacterApplicationRefGene cloningCompany
anti-hCCR11 mAb
in preparation
Back to list

human CXCR1CharacterApplicationRefGene cloningCompany
anti-hCXCR1 mAb
in preparation
Back to list

human CXCR2CharacterApplicationRefGene cloningCompany
anti-hCXCR2 mAb
in preparation
Back to list

human CXCR3CharacterApplicationRefGene cloningCompany
anti-hCXCR3 mAb
in preparation
Back to list

human CXCR4CharacterApplicationRefGene cloningCompany
anti-hCXCR4 mAb
in preparation
Back to list

human CXCR5CharacterApplicationRefGene cloningCompany
anti-hCXCR5 mAb
in preparation
Back to list

human CXCR6CharacterApplicationRefGene cloningCompany
anti-hCXCR6 mAb
in preparation
Back to list

human CXCR7CharacterApplicationRefGene cloningCompany
anti-hCXCR7 mAb
in preparation
Back to list

human XCR1
CharacterApplicationRefGene cloningCompany
anti-hXCR1 mAb (X1Mab-4; mouse IgG1, kappa) specific for human XCR1; established by peptide immunization FACS done
anti-hXCR1 mAb (X1Mab-29; mouse IgM, kappa) specific for human XCR1; established by peptide immunization FACS done
anti-hXCR1 mAb (X1Mab-47; mouse IgM, kappa) specific for human XCR1; established by CBIS (immunization of MDA-MB-157/PA-hXCR1) FACS
Back to list





EGFR/HER2/HER3/HER4
mouse EGFR
domain-I
Character
--> human EGFR
ApplicationRefGene cloningCompany
anti-EGFR mAb; EMab-300 (rat IgG1, kappa) specific for mouse EGFR FACS EMab-300 done
mouse EGFR
domain-II
CharacterApplicationRefGene cloningCompany
anti-EGFR mAb; EMab-301 (rat IgM, kappa) specific for mouse EGFR FACS
anti-EGFR mAb; EMab-301-rG2a-f (rat IgG2a, kappa) specific for mouse EGFR FACS
mouse EGFR
domain-III
CharacterApplicationRefGene cloningCompany
anti-mouse/human EGFR mAb; EMab-88 (mouse IgG1, kappa) specific for EGFR; EMab-88 was developed against human EGFR; crossreacts with mouse EGFR (domain-III) FACS data done
human EGFR
domain-I
CharacterApplicationRefGene cloningCompany
anti-EGFR mAb
(EMab-23; mouse IgG1, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-I FACS done
anti-EGFR mAb
(EMab-78; mouse IgG2b, kappa)
specific for EGFR; reacts with domain-I FACS done
anti-EGFR mAb
(EMab-129; mouse IgG1, lambda)
specific for EGFR; reacts with domain-I FACS done
human EGFR
domain-II
CharacterApplicationRefGene cloningCompany
anti-EGFR mAb
(EMab-19; mouse IgG2a, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-II FACS done
anti-EGFR mAb
(EMab-33; mouse IgG1, kappa)
specific for EGFR; reacts with domain-II FACS done
anti-EGFR mAb
(EMab-57; mouse IgG1, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-II FACS done
anti-EGFR mAb
(EMab-76; mouse IgG1, kappa)
specific for EGFR; reacts with domain-II FACS done
human EGFR
domain-III
CharacterApplicationRefGene cloningCompany
anti-EGFR mAb
(EMab-134; mouse IgG1, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, WB, IHC EMab-134
epitope-1; -2
AirID
done abcam
BD
anti-EGFR mAb
(134-mG2a; mouse IgG2a, kappa)
mouse IgG2a version of EMab-134; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, WB, IHC, ADCC/CDC, antitumor activities 134-mG2a done
anti-EGFR mAb
(EMab-51; mouse IgG1, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, WB, IHC EMab-51
epitope
done
anti-EGFR mAb
(51-mG2a; mouse IgG2a, kappa)
mouse IgG2a version of EMab-51specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, WB, IHC, ADCC, CDC, antitumor activities done
anti-EGFR mAb
(51-mG2a-f; mouse IgG2a, kappa)
core fucose-deficient mouse IgG2a version of EMab-51; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, WB, IHC, ADCC, CDC, antitumor activities done
anti-EGFR mAb
(EMab-17; mouse IgG2a, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, ADCC/CDC, antitumor activities EMab-17
metastasis
done
anti-EGFR mAb
(recEMab-17-f; mouse IgG2a)
core fucose-deficient mouse IgG2a version of EMab-17; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, ADCC/CDC, antitumor activities done
anti-EGFR mAb
(EMab-1; mouse IgG1, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS done
anti-EGFR mAb
(EMab-32; mouse IgG2a, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS done
anti-EGFR mAb
(EMab-114; mouse IgG2b, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS done
anti-EGFR mAb
(EMab-125; mouse IgG1, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, WB done
anti-EGFR mAb
(EMab-139; mouse IgG1, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS, WB done
anti-EGFR mAb
(EMab-151; mouse IgG2b, kappa)
specific for EGFR; crossreacts with dog EGFR; reacts with domain-III FACS done
anti-EGFR mAb
(cetuximab; human IgG1,kappa)
specific for EGFR (Erbitax) FACS
anti-EGFR mAb
(panitumumab; human IgG2,kappa)
specific for EGFR (Vectibix; epitope) FACS done
human EGFR
domain-IV
CharacterApplicationRefGene cloningCompany
anti-EGFR mAb
(EMab-95; mouse IgG1, kappa)
specific for EGFR; reacts with domain-IV FACS done
anti-EGFR mAb
(EMab-110; mouse IgG1, kappa)
specific for EGFR; reacts with domain-IV FACS done
dog EGFRCharacterApplicationRefGene cloningCompany
anti-EGFR mAb
(134-mG2a-f; mouse IgG2a)
core fucose-deficient mouse IgG2a version of EMab-134; reacts with domain-III FACS, WB, IHC, ADCC, CDC, antitumor activities CHO/dEGFR
OS; Fibro
Mammary
done
anti-EGFR mAb
(E134Bf; canine IgGB, kappa)
core fucose-deficient canine IgGB version of EMab-134; specific for EGFR FACS, WB, IHC, ADCC, CDC, antitumor activities Mammary
Fibro & Osteo
done
bispecificCharacterApplicationRefGene cloningCompany
anti-dog EGFR-dog HER2 mAb
(E134B-H77scFv-f)
bispecific mAb for EGFR and HER2 FACS, WB, IHC, ADCC, CDC, antitumor activities E134B-H77scFv-f done
anti-EGFR-PDPN mAb
(E134-NZ1scFv-mG2a-f)
bispecific mAb for EGFR and PDPN FACS, WB, IHC, ADCC, CDC, antitumor activities done
Back to list

mouse HER2
(
CD340)
CharacterApplicationRefGene cloningCompany
anti-HER2 mAb
(H2Mab-300
; rat IgG2b, kappa)
specific for mouse HER2 (domain-I)
does not cross-react with dog HER2
FACS H2Mab-300 done
anti-HER2 mAb
(H2Mab-303
; rat IgG2a, kappa)
specific for mouse HER2 (domain-I)
does not cross-react with dog HER2
FACS done
anti-HER2 mAb
(H2Mab-304
; rat IgG1, kappa)
specific for mouse HER2 (domain-I)
does not cross-react with dog HER2
FACS, WB H2Mab-304 done
anti-HER2 mAb
(H2Mab-307
; rat IgG2a, kappa)
specific for mouse HER2 (domain-I)
does not cross-react with dog HER2
FACS done
anti-HER2 mAb
(H2Mab-314
; rat IgG1, kappa)
specific for mouse HER2
does not cross-react with dog HER2
FACS, WB done
anti-HER2 mAb
(H2Mab-1301;
rat IgG2a, lambda)
Mab30; specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2 FACS done
anti-HER2 mAb
(H2Mab-1301-hG1
;human IgG1,kappa)
specific for mouse HER2;
cross-react with HER2 (human)
does not cross-react with dog HER2
FACS ongoing
anti-HER2 mAb
(H2Mab-1316;
rat IgG2a, kappa)
Mab-31; specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2 FACS done
anti-HER2 mAb
(H2Mab-1316-hG1
;human IgG1,kappa)
specific for mouse HER2;
cross-react with HER2 (human)
does not cross-react with dog HER2
FACS ongoing
anti-HER2 mAb
(H2Mab-1319;
rat IgG2a, kappa)
Mab-32; specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2 FACS done
anti-HER2 mAb
(H2Mab-1319-hG1
;human IgG1,kappa)
specific for mouse HER2;
cross-react with HER2 (human)
does not cross-react with dog HER2
FACS ongoing
HER2
domain-I
CharacterApplicationRefGene cloningCompany
anti-HER2 mAb
(H2Mab-77; mouse IgG1, kappa)
specific for HER2; crossreacts with dog HER2; (ref: TNBC) FACS, WB, IHC H2Mab-77 done BioLegnd
anti-HER2 mAb
(H2Mab-77-mG2a-f; mouse IgG2a)
specific for HER2; crossreacts with dog HER2; (ref: TNBC) FACS, WB, IHC 77-mG2a-f done
anti-HER2 mAb
(H2Mab-77-hG1; human IgG1)
specific for HER2; crossreacts with dog HER2; (ref: TNBC) FACS, WB, IHC done
anti-HER2 mAb
(H77Bf; canine IgGB, kappa)
core fucose-deficient canine IgGB version of H2Mab-77 FACS, WB, IHC, ADCC/CDC, antitumor activities H77Bf
OS
fibro
done
anti-HER2 mAb
(H2Mab-119; mouse IgG1, kappa)
specific for HER2; crossreacts with dog HER2 FACS, WB, IHC H2Mab-119
structure
H2Mab-250
done
anti-HER2 mAb
(H2Mab-119-mG2a-f; mouse IgG2a)
specific for HER2; crossreacts with dog HER2 FACS, WB, IHC 119-mG2a-f done
anti-HER2 mAb
(H2Mab-119-hG1; human IgG1)
specific for HER2; crossreacts with dog HER2 FACS, WB, IHC done
anti-HER2 mAb
(H2Mab-139; mouse IgG1, kappa)
specific for HER2; crossreacts with dog HER2 FACS, WB, IHC H2Mab-139 done abcam
anti-HER2 mAb
(H2Mab-139-mG2a;mouse IgG2a)
specific for HER2; crossreacts with dog HER2 FACS, WB, IHC done
anti-HER2 mAb
(H2Mab-139-mG2a-f; mouse IgG2a)
specific for HER2; crossreacts with dog HER2 FACS, WB, IHC 139-mG2a-f done
anti-HER2 mAb
(H2Mab-1245;
mouse IgG1,kappa)
Mab-34; specific for human HER2
does not cross-react with endogenous dog HER2
FACS done
anti-HER2 mAb
(H2Mab-1268;
mouse IgG1,kappa)
Mab-35; specific for HER2 or endogenous dog HER2 FACS done
anti-HER2 mAb
(H2Mab-1278;
mouse IgG1,kappa)
Mab-38; specific for HER2 or endogenous dog HER2 FACS done
HER2
domain-II
CharacterApplicationRefGene cloningCompany
anti-HER2 mAb
(H2Mab-32; mouse IgG1, kappa)
specific for HER2 FACS

done
anti-HER2 mAb
(H2Mab-133; mouse IgG1, kappa)
specific for HER2 FACS

done
anti-HER2 mAb
(H2Mab-193; mouse IgG1, kappa)
specific for HER2 FACS H2Mab-250 done
anti-HER2 mAb
(H2Mab-215; mouse IgG1, kappa)
specific for HER2 FACS H2Mab-250 done
(anti-HER2 mAb
(pertuzumab; human IgG1,kappa)
specific for HER2 (Perjeta) FACS done
HER2
domain-III
CharacterApplicationRefGene cloningCompany
anti-HER2 mAb
(H2Mab-19; mouse IgG2b, kappa)
specific for HER2; crossreacts with mouse HER2 or dog HER2; domain-III FACS, ADCC/CDC, antitumor activities PC
CRC
GBM
done
anti-HER2 mAb
(H2Mab-181; mouse IgG1, kappa)
specific for HER2; crossreacts with dog HER2; domain-III; epitope: p373-392 FACS, WB, IHC H2Mab-181
epitope
done
anti-HER2 mAb
(H2Mab-1180;
mouse IgG1, kappa)
Mab-33; specific for human HER2
does not cross-react with endogenous dog HER2
FACS done
anti-HER2 mAb
(H2Mab-1190;
mouse IgG1,kappa)
Mab-36; specific for HER2
does not cross-react with endogenous dog HER2
FACS done
anti-HER2 mAb
(H2Mab-1262;
mouse IgG1,kappa)
Mab-37; specific for HER2
does not cross-react with endogenous dog HER2
FACS done
HER2
domain-IV
CharacterApplicationRefGene cloningCompany
anti-HER2 mAb
(H2Mab-41; mouse IgG2b, kappa)
specific for HER2; crossreacts with dog HER2; domain-IV FACS, antitumor activities H2Mab-41 dogHER2
done
(anti-HER2 mAb
(trastuzumab; human IgG1,kappa)
specific for HER2 FACS H2Mab-250
H2Mab-214
done
anti-HER2 mAb
(trastuzumab-f;
human IgG1,kappa)
defucosylated trastuzumab; specific for HER2 FACS 250_in vivo
done
anti-HER2 mAb
(tras-mG2a-f;
mouse IgG2a,kappa)
specific for HER2
mouse IgG2a-version of trastuzumab
defucosylated
FACS 250_in vivo done
anti-HER2 mAb
(H2Mab-214;
mouse IgG1,kappa)
H2CasMab-1; specific for HER2; domain-IV
PCT/JP2021/043538
FACS, WB, IHC H2Mab-214 done
anti-HER2 mAb
(H2Mab-214-mG2af; mouse IgG2a,kappa)
H2CasMab-1; specific for HER2; domain-IV FACS, WB, IHC 214-mG2a-f done
anti-HER2 mAb
(H2Mab-214-hG1; human IgG1,kappa)
H2CasMab-1; specific for HER2; domain-IV FACS, WB, IHC done
Back to list

HER3CharacterApplicationRefGene cloningCompany
anti HER3 mAb
(H3Mab-17; mouse IgG2a, kappa)
specific for HER3 FACS, ADCC/CDC, antitumor activities H3Mab-17 done exbio
anti-HER3 mAb
(patritumab; human IgG2,kappa)
specific for HER3 (Patritumab) FACS
Back to list

HER4CharacterApplicationRefGene cloningCompany
anti-HER4 mAb (H4Mab-12; mouse IgG2a, kappa) Kd: 3.1 x 10^-10 M for T-47D
ref: clone P6-1 (BD; CosmoBio: rat IgG2a;
Kd: 2.8 x 10^-10 M for T-47D)
FACS done
anti-HER4 mAb (H4Mab-16; mouse IgG1, kappa) immunization of LN229/HER4
Kd: 1.2 x 10^-9 M for T-47D
FACS done
Back to list



Immune checkpoint
KLRG1CharacterApplicationRefGene cloningCompany
anti-KLRG1 mAb
(KLMab-1; mouse IgG1, kappa)
specific for human KLRG1 FACS, ICC KLMab-1
ICC
done
Back to list

PD-L1
(
CD274/B7H1)
CharacterApplicationRefGene cloningCompany
anti-PD-L1 mAb
(L1Mab-13; mouse IgG1, kappa)
specific for human PD-L1 FACS, WB, IHC (cell), IHC (tissue), ELISA L1Mab-13 done
anti-PD-L1 mAb
(13-mG2a-f; mouse IgG2a, kappa)
specific for human PD-L1; core fucose-deficient IgG2a of L1Mab-13 FACS, WB, IHC (cell), IHC (tissue), ELISA, ADCC/CDC, antitumor activities 13-mG2a-f done
dog PD-L1
CharacterApplicationRefGene cloningCompany
anti-dog PD-L1 mAb
(L1Mab-347; mouse IgG1, kappa)
specific for dog PD-L1 (extracellular domain) FACS, IHC done
anti-dog PD-L1 mAb
(L1Mab-352;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA, IHC L1Mab-352 done
anti-dog PD-L1 mAb
(L1Mab-354;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA, IHC L1Mab-354 done
Back to list

PD-L2
(
CD273/B7H2)
CharacterApplicationRefGene cloningCompany
anti-PD-L2 mAb
(L2Mab-1; mouse IgG2b, kappa)
specific for PD-L2 FACS, WB, IHC (cell) done
Back to list

TIGITCharacterApplicationRefGene cloningCompany
anti-TIGIT mAb
(TgMab-1; mouse IgG1, kappa)
specific for TIGIT FACS
KD: 6.7 x 10^-10
done
anti-TIGIT mAb
(TgMab-2; mouse IgG1, kappa)
specific for TIGIT FACS, WB, ICC
KD: 3.5 x 10^-9
TgMab-2
ICC
done BD
Back to list





Monoclonal antibodies for the other membrane proteins
CA4CharacterApplicationRefGene cloningCompany
anti-CA4 mAb
(CA4Mab-1; rat IgG1, kappa)
specific for mouse carbonic anhydrase IV (CA4) FACS, ELISA done
anti-CA4 mAb
(CA4Mab-2; rat IgG1, kappa)
specific for mouse carbonic anhydrase IV (CA4) FACS, ELISA done
Back to list

CD10CharacterApplicationRefGene cloningCompany
anti-CD10 mAb
(C10Mab-31; mouse IgG1, kappa)
specific for CD10; CBIS method FACS C10Mab-31
RCC
done
Back to list

CD19CharacterApplicationRefGene cloningCompany
anti-CD19 mAb
(C19Mab-1; mouse IgG1, kappa)
specific for CD19; CBIS method; LN229/CD19 immunization FACS C19Mab-1 done
anti-CD19 mAb
(C19Mab-3; mouse IgG1, kappa)
specific for CD19; CBIS method; ectodomain of CD19 immunization IHC,WB C19Mab-3 done
Back to list

CD20CharacterApplicationRefGene cloningCompany
anti-CD20 mAb
(C20Mab-11; mouse IgM, kappa)
specific for CD20 FACS, WB, IHC C20Mab-11
epitope
ongoing
anti-CD20 mAb
(C20Mab-60; mouse IgG2a, kappa)
specific for CD20; ref: rituximab FACS, WB, IHC C20Mab-60
epitope-1
epitope-2
done BioLegnd
anti-CD20 mAb
(rituximab; human IgG1, kappa)
specific for human CD20 (Rituxan) FACS done
anti-CD20 mAb
(obinutuzumab; human IgG1, kappa)
specific for human CD20 (GAZYVA;type II) FACS
Back to list

CD39CharacterApplicationRefGene cloningCompany
anti-CD39 mAb
(C39Mab-1; rat IgG2a, kappa)
specific for mouse CD39 FACS, WB C39Mab-1
epitope
done
anti-CD39 mAb
(C39Mab-1-ratM; rat IgM, kappa)
specific for mouse CD39 FACS, WB done
anti-CD39 mAb
(C39Mab-2; rat IgG2a, lambda)
specific for mouse CD39 FACS C39Mab-2 done
Back to list

CD44sCharacterApplicationRefGene cloningCompany
anti-CD44s mAb
(C44Mab-5;
mouse IgG1, kappa)
Specific for CD44s (CD44 standard) IHC, FACS, WB C44Mab-5
epitope
done abcam BioLegnd
anti-CD44s mAb
(5-mG2a-f;
mouse IgG2a)
mouse IgG2a version of C44Mab-5; specific for CD44s (CD44 standard) IHC, FACS, ADCC, CDC, antitumor activities 5-mG2a-f done
anti-CD44s mAb
(C44Mab-46;
mouse IgG1, kappa)
specific for CD44s (CD44 standard) FACS, IHC, WB C44Mab-46
epitope-1
epitope-2
done
anti-CD44s mAb
(C44Mab-46-mG2a-f; mouse IgG2a)
mouse IgG2a version of C44Mab-46
specific for CD44s (CD44 standard)
IHC, FACS, WB C44Mab-46-mG2a-f done
Back to list

CD44v3CharacterApplicationRefGene cloningCompany
anti-CD44v3 mAb
(C44Mab-6;
mouse IgG1, kappa)
specific for CD44v3
(oral cancer and colon cancer)
FACS, WB, IHC, ELISA C44Mab-6(IJMS)
FACS(CAS)
done
anti-CD44v3 mAb
(C44Mab-6-mG2a-f; mouse IgG2a)
IgG2a version of C44Mab-6 FACS, WB, IHC, ELISA ongoing ongoing
CD44v4CharacterApplicationRefGene cloningCompany
anti-CD44v4 mAb
(C44Mab-108;
mouse IgG1, kappa)
specific for CD44v4
(oral cancer)
WB, IHC, ELISA C44Mab-108
epitope
done Merck
anti-CD44v4 mAb
(C44Mab-112;
mouse IgG1, kappa)
specific for CD44v4
crossreact with mouse CD44
WB, IHC, ELISA done
anti-CD44v4 mAb
(C44Mab-118;
mouse IgG1, kappa)
specific for CD44v4
crossreact with mouse CD44
WB, IHC, ELISA done
CD44v5CharacterApplicationRefGene cloningCompany
anti-CD44v5 mAb
(C44Mab-3;
mouse IgG1, kappa)
specific for CD44v5
(pancreatic cancer)
FACS, WB, IHC, ELISA C44Mab-3
(antibodies)
done Merck
anti-CD44v5 mAb
(C44Mab-3-mG2a-f; mouse IgG2a)
IgG2a version of C44Mab-3 FACS, WB, IHC, ELISA ongoing ongoing
CD44v6CharacterApplicationRefGene cloningCompany
anti-CD44v6 mAb
(C44Mab-9;
mouse IgG1, kappa)
specific for CD44v6
(colon cancer)
FACS, WB, IHC, ELISA C44Mab-9
(IJMS)
done Merck
anti-CD44v6 mAb
(C44Mab-9-mG2a-f; mouse IgG2a)
IgG2a version of C44Mab-9 FACS, WB, IHC, ELISA ongoing ongoing
anti-CD44v6 mAb
(bivatuzumab;
human IgG1, kappa)
specific for CD44v6 ref done
anti-CD44v6 mAb
(biva-mG1;
mouse IgG2a, kappa)
specific for CD44v6
mouse IgG1 type
CD44v7CharacterApplicationRefGene cloningCompany
anti-CD44v7/v8 mAb
(C44Mab-34;
mouse IgG1, kappa)
specific for CD44v7/v8
(oral cancer)
FACS, WB, IHC, ELISA C44Mab-34
(Biomedicines)
done
anti-CD44v7/v8 mAb
(C44Mab-34-mG2a-f; mouse IgG2a)
mouse IgG2a version of C44Mab-34 FACS, WB, IHC, ELISA ongoing ongoing
CD44v8CharacterApplicationRefGene cloningCompany
anti-CD44v8 mAb
(C44Mab-94;
mouse IgG1, kappa)
specific for CD44v8
(gastric cancer)
FACS, WB, IHC, ELISA C44Mab-94
(antibodies)
done
anti-CD44v8 mAb
(C44Mab-94-mG2a-f; mouse IgG2a)
mouse IgG2a version of C44Mab-94 FACS, WB, IHC, ELISA ongoing ongoing
CD44v9CharacterApplicationRefGene cloningCompany
anti-CD44v9 mAb
(C44Mab-1;
mouse IgG1, kappa)
specific for CD44v9
(colon cancer)
FACS, WB, IHC, ELISA C44Mab-1(CIMB)
FACS(CAS)
done
anti-CD44v9 mAb
(C44Mab-1-mG2a-f; mouse IgG2a)
mouse IgG2a version of C44Mab-1 FACS, WB, IHC, ELISA ongoing ongoing
CD44v10CharacterApplicationRefGene cloningCompany
anti-CD44v10 mAb
(C44Mab-18;
mouse IgM, kappa)
specific for CD44v10
(oral cancer)
FACS, WB, IHC, ELISA C44Mab-18
(CIMB)
done
anti-CD44v10 mAb
(C44Mab-18-mG1;
mouse IgG1, kappa)
mouse IgG1 version of CD44v10 FACS, WB, IHC, ELISA done
anti-CD44v10 mAb
(C44Mab-18-mG2a-f; mouse IgG2a)
mouse IgG2a version of C44Mab-18 FACS, WB, IHC, ELISA ongoing done
Back to list

CD73CharacterApplicationRefGene cloningCompany
anti-CD73 mAb (C73Mab-1; rat Ig) specific for mouse CD73 FACS in preparation
(Kaneko et al)
anti-CD73 mAb (C73Mab-2; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-3; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-4; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-5; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-6; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-7; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-8; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-9; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-10; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-11; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-12; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-13; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-14; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-15; rat Ig) specific for mouse CD73 FACS
anti-CD73 mAb (C73Mab-16; rat Ig) specific for mouse CD73 FACS
Back to list

CD133CharacterApplicationRefGene cloningCompany
anti-CD133 mAb
(CMab-43; mouse IgG2a, kappa)
specific for CD133 FACS, WB, IHC, ADCC/CDC,
antitumor activities
CMab-43
in vivo
done abcam
BD
anti-CD133 mAb
(CMab-44; mouse IgG1, kappa)
specific for CD133;
detects AML
FACS, WB done
Back to list

CD271
(NGFR)
CharacterApplicationRefGene cloningCompany
anti-CD271 mAb
(G4B1; mouse IgG2a, kappa)
cancer-specific mAb for CD271 FACS, WB, IHC anti-CD271 mAb done Merck
Back to list

CD273
(
PD-L2/B7H2)
CharacterApplicationRefGene cloningCompany
anti-PD-L2 mAb --> PD-L2
Back to list

CD274
(
PD-L1/B7H1)
CharacterApplicationRefGene cloningCompany
anti-PD-L1 mAb --> PD-L1
Back to list

CD276
(B7H3)
CharacterApplicationRefGene cloningCompany
anti-CD276 mAb specific for CD276
Back to list

CDH1CharacterApplicationRefGene cloningCompany
anti-CDH1 mAb
Ca1Mab series
specific for CDH1
Back to list

CDH2CharacterApplicationRefGene cloningCompany
anti-CDH2 mAb
Ca2Mab series
specific for CDH2
Back to list

CDH4CharacterApplicationRefGene cloningCompany
anti-CDH4 mAb
Ca4Mab series
specific for CDH4
Back to list

CDH5CharacterApplicationRefGene cloningCompany
anti-CDH5 mAb
Ca5Mab series
specific for CDH5
Back to list

CDH6CharacterApplicationRefGene cloningCompany
anti-CDH6 mAb
Ca6Mab series
specific for CDH6
Back to list

CDH7CharacterApplicationRefGene cloningCompany
anti-CDH7 mAb
Ca7Mab series
specific for CDH7
Back to list

CDH8CharacterApplicationRefGene cloningCompany
anti-CDH8 mAb
Ca8Mab series
specific for CDH8
Back to list

CDH9CharacterApplicationRefGene cloningCompany
anti-CDH9 mAb
Ca9Mab series
specific for CDH9
Back to list

CDH10CharacterApplicationRefGene cloningCompany
anti-CDH10 mAb
Ca10Mab series
specific for CDH10
Back to list

CDH11CharacterApplicationRefGene cloningCompany
anti-CDH11 mAb
Ca11Mab series
specific for CDH11
Back to list

CDH12CharacterApplicationRefGene cloningCompany
anti-CDH12 mAb
Ca12Mab series
specific for CDH12
Back to list

CDH13CharacterApplicationRefGene cloningCompany
anti-CDH13 mAb
Ca13Mab series
specific for CDH13
Back to list

CDH15CharacterApplicationRefGene cloningCompany
anti-CDH15 mAb
Ca15Mab series
specific for CDH15
Back to list

CDH16CharacterApplicationRefGene cloningCompany
anti-CDH16 mAb
Ca16Mab series
specific for CDH16
Back to list

CDH17CharacterApplicationRefGene cloningCompany
anti-CDH17 mAb
Ca17Mab series
specific for CDH17
Back to list

CDH18CharacterApplicationRefGene cloningCompany
anti-CDH18 mAb
Ca18Mab series
specific for CDH18
Back to list

CDH19CharacterApplicationRefGene cloningCompany
anti-CDH19 mAb
Ca19Mab series
specific for CDH19
Back to list

CDH20CharacterApplicationRefGene cloningCompany
anti-CDH20 mAb
Ca20Mab series
specific for CDH20
Back to list

CDH21CharacterApplicationRefGene cloningCompany
anti-CDH21 mAb
Ca21Mab series
specific for CDH21
Back to list

CDH22CharacterApplicationRefGene cloningCompany
anti-CDH22 mAb
Ca22Mab series
specific for CDH22
Back to list

CDH23CharacterApplicationRefGene cloningCompany
anti-CDH23 mAb
Ca23Mab series
specific for CDH23
Back to list

CDH24CharacterApplicationRefGene cloningCompany
anti-CDH24 mAb
Ca24Mab series
specific for CDH24
Back to list

CDH25CharacterApplicationRefGene cloningCompany
anti-CDH25 mAb
Ca25Mab series
specific for CDH25
Back to list

mouse EpCAM
(CD326)
CharacterApplicationRefGene cloningCompany
anti-EpCAM mAb
(EpMab-160; rat IgG2b, kappa)
specific for mouse EpCAM FACS in preparation (Li G et al)
anti-EpCAM mAb
(EpMab-161; rat IgG2b, kappa)
specific for mouse EpCAM FACS
anti-EpCAM mAb
(EpMab-162; rat IgG2a, kappa)
specific for mouse EpCAM FACS
anti-EpCAM mAb
(EpMab-163; rat IgG2c, kappa)
specific for mouse EpCAM FACS
anti-EpCAM mAb
(EpMab-164; rat IgM, kappa)
specific for mouse EpCAM FACS
anti-EpCAM mAb
(EpMab-165; rat IgG2a, kappa)
specific for mouse EpCAM FACS
anti-EpCAM mAb
(EpMab-166; rat IgM, kappa)
specific for mouse EpCAM
crossreact with human EpCAM (only exogenous)
FACS
anti-EpCAM mAb
(EpMab-167; rat IgM, kappa)
specific for mouse EpCAM FACS
human EpCAM
(CD326)
CharacterApplicationRefGene cloningCompany
anti-EpCAM mAb
(EpMab-16; mouse IgG2a, kappa)
specific for EpCAM FACS, WB, IHC EpMab-16 (1)
EpMab-16 (2)
done merck
anti-EpCAM mAb
(EpMab-37; mouse IgG1, kappa)
specific for EpCAM FACS, WB, IHC EpMab-37
epitope
done
anti-EpCAM mAb
(EpMab-37-mG2a-f; mouse IgG2a)
specific for EpCAM FACS, WB, IHC, ADCC, CDC,
antitumor activities
EpMab-37 (1)
EpMab-37 (2)
done
anti-EpCAM mAb
(EpMab-3; mouse IgG1, kappa)
specific for EpCAM FACS done
Back to list

EphA2CharacterApplicationRefGene cloningCompany
anti-EphA2 mAb
Ea2Mab-1 (mouse IgG1, kappa)
specific for EphA2
ref: clone SHM16 (BioLegend; Kd: 8.4 x 10^-9 for CHO/hEphA2)
FACS
anti-EphA2 mAb
Ea2Mab-2 (mouse IgG2a, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-3 (mouse IgG1, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-4 (mouse IgG2b, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-5 (mouse IgG1, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-6 (mouse IgG1, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-7 (mouse IgG1, kappa)
specific for EphA2
Kd: 7.7 x 10^-9 for CHO/hEphA2
FACS, WB, IHC (cell) in preparation
(Satofuka et al)
anti-EphA2 mAb
Ea2Mab-8 (mouse IgG1, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-9 (mouse IgG1, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-10 (mouse IgG1, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-11 (mouse IgG1, kappa)
specific for EphA2 FACS
anti-EphA2 mAb
Ea2Mab-12 (mouse IgG1, kappa)
specific for EphA2 FACS
Back to list

EphA3CharacterApplicationRefGene cloningCompany
anti-EphA3 mAb
Ea3Mab-1 (mouse IgG1, kappa)
specific for EphA3; Kd: 4.9 x 10^-9; ref: clone: IIIA4 (absolute antibody; Kd: 1.4 x 10^-) FACS in preparation
(Hirose et al)
anti-EphA3 mAb
Ea3Mab-2 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-3 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-4 (mouse IgG1, kappa)
specific for EphA3; Kd: 2.3 x 10^-9 FACS
anti-EphA3 mAb
Ea3Mab-5 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-6 (mouse IgM, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-7 (mouse IgG1, kappa)
specific for EphA3; Kd: 6.7 x 10^-9 FACS
anti-EphA3 mAb
Ea3Mab-8 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-9 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-10 (mouse IgG1, kappa)
specific for EphA3; Kd: 2.5 x 10^-9 FACS
anti-EphA3 mAb
Ea3Mab-11 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-12 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-13 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-14 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-15 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-16 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-17 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-18 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-19 (mouse IgG1, kappa)
specific for EphA3 FACS
anti-EphA3 mAb
Ea3Mab-20 (mouse IgG1, kappa)
specific for EphA3 FACS
Back to list

EphA4CharacterApplicationRefGene cloningCompany
anti-EphA4 mAb
Ea4Mab-1 (mouse IgG1, kappa)
specific for EphA4 FACS in preparation
(Li et al)
anti-EphA4 mAb
Ea4Mab-2 (mouse IgG1, kappa)
specific for EphA4 FACS
anti-EphA4 mAb
Ea4Mab-3 (mouse IgG1, kappa)
specific for EphA4 FACS
anti-EphA4 mAb
Ea4Mab-4 (mouse IgG2b, kappa)
specific for EphA4 FACS
anti-EphA4 mAb
Ea4Mab-5 (mouse IgG1, kappa)
specific for EphA4 FACS
anti-EphA4 mAb
Ea4Mab-6 (mouse IgG1, kappa)
specific for EphA4 FACS
Back to list

EphA5CharacterApplicationRefGene cloningCompany
anti-EphA5 mAb
Ea5Mab-1 (mouse IgG1, kappa)
specific for human EphA5
established by CBIS method
FACS in preparation
(Li et al)
anti-EphA5 mAb
Ea5Mab-2 (mouse IgG1, kappa)
specific for human EphA5
established by CBIS method
FACS
anti-EphA5 mAb
Ea5Mab-3 (mouse IgG1, kappa)
specific for human EphA5
established by CBIS method
FACS
anti-EphA5 mAb
Ea5Mab-4 (mouse IgG1, kappa)
specific for human EphA5
established by CBIS method
FACS
anti-EphA5 mAb
Ea5Mab-5 (mouse IgG1, kappa)
specific for human EphA5
established by CBIS method
FACS
anti-EphA5 mAb
Ea5Mab-6 (mouse IgG1, kappa)
specific for human EphA5
established by CBIS method
FACS
anti-EphA5 mAb
Ea5Mab-7 (mouse IgG1, kappa)
specific for human EphA5
established by CBIS method
FACS
Back to list

EphA6CharacterApplicationRefGene cloningCompany
anti-EphA6 mAb
(Ea6Mab-1, mouse IgG1, kappa)
specific for human EphA6
established by CBIS method
no ref mAb
FACS in preparation
(Li G et al)
Back to list

EphA7CharacterApplicationRefGene cloningCompany
anti-EphA7 mAb
Ea7Mab-1 (mouse IgM, kappa)
specific for human EphA7 FACS in preparation
(Yamamoto et al)
anti-EphA7 mAb
Ea7Mab-2 (mouse IgG1, kappa)
specific for human EphA7 FACS
anti-EphA7 mAb
Ea7Mab-3 (mouse IgG1, kappa)
specific for human EphA7 FACS
anti-EphA7 mAb
Ea7Mab-4 (mouse IgG1, kappa)
specific for human EphA7 FACS
anti-EphA7 mAb
Ea7Mab-5 (mouse IgG1, kappa)
specific for human EphA7 FACS
anti-EphA7 mAb
Ea7Mab-6 (mouse IgG1, kappa)
specific for human EphA7 FACS
anti-EphA7 mAb
Ea7Mab-7 (mouse IgG1, kappa)
specific for human EphA7 FACS
anti-EphA7 mAb
Ea7Mab-8 (mouse IgG1, kappa)
specific for human EphA7 FACS
anti-EphA7 mAb
Ea7Mab-9 (mouse IgG1, kappa)
specific for human EphA7 FACS
anti-EphA7 mAb
Ea7Mab-10 (mouse IgG1, kappa)
specific for human EphA7 FACS
Back to list

EphA8CharacterApplicationRefGene cloningCompany
anti-EphA8 mAb
(Ea8Mab-1, mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
no ref mAb
FACS in preparation (Yamamoto et al)
anti-EphA8 mAb
(Ea8Mab-2, mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-3, mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-4, mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-5, mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-6,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-7,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-8,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-9,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-10,mouse IgG1, lambda)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-11,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-12,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-13,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-14,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-15,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-16,mouse IgG3, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-17,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
anti-EphA8 mAb
(Ea8Mab-18,mouse IgG1, kappa)
specific for human EphA8
established by CBIS method
FACS
Back to list

EphA10CharacterApplicationRefGene cloningCompany
anti-EphA10 mAb
Ea10Mab-1 (mouse IgG1, kappa)
specific for human EphA10
established by CBIS method
FACS in preparation
(Ubukata et al)
Back to list

EphB1CharacterApplicationRefGene cloningCompany
anti-EphB1 mAb
Eb1Mab-1 (mouse IgG1, kappa)
specific for human EphB1
Kd: 4.1 x 10^-9 M
FACS in preparation
(Yamamoto et al)
anti-EphB1 mAb
Eb1Mab-2 (mouse IgM, kappa)
specific for human EphB1 FACS
anti-EphB1 mAb
Eb1Mab-3 (mouse IgG1, kappa)
specific for human EphB1
Kd: 2.5 x 10^-9 M
FACS
Back to list

EphB2CharacterApplicationRefGene cloningCompany
anti-EphB2 mAb
Eb2Mab-1 (mouse IgG1, kappa)
specific for human EphB2; Kd: 5.9 x 10^-9 for CHO/hEphB2; ref: clone 2H9 (BD; 3.4 x 10^-9 for CHO/hEphB2; Kd: 1.9 x 10^-9 for LS174T) FACS
anti-EphB2 mAb
Eb2Mab-2 (mouse IgG1, kappa)
specific for human EphB2; Kd: 6.4 x 10^-9 for CHO/hEphB2 FACS
anti-EphB2 mAb
Eb2Mab-3 (mouse IgG1, kappa)
specific for human EphB2; Kd: 1.1 x 10^-9 for CHO/hEphB2; 3.6 x 10^-10 for LS174T FACS Eb2Mab-3
anti-EphB2 mAb
Eb2Mab-4 (mouse IgG1, kappa)
specific for human EphB2; Kd: 3.3 x 10^-9 for CHO/hEphB2 FACS
anti-EphB2 mAb
Eb2Mab-5 (mouse IgG3, kappa)
specific for human EphB2 FACS
anti-EphB2 mAb
Eb2Mab-6 (mouse IgM, kappa)
specific for human EphB2 FACS
anti-EphB2 mAb
Eb2Mab-7 (mouse IgG1, kappa)
specific for human EphB2; Kd: 5.2 x 10^-9 for CHO/hEphB2 FACS
anti-EphB2 mAb
Eb2Mab-8 (mouse IgG1, kappa)
specific for human EphB2; Kd: 9.5 x 10^-9 for CHO/hEphB2 FACS
anti-EphB2 mAb
Eb2Mab-9 (mouse IgM, kappa)
specific for human EphB2 FACS
anti-EphB2 mAb
Eb2Mab-10 (mouse IgG1, kappa)
specific for human EphB2; Kd: 3.4 x 10^-9 for CHO/hEphB2 FACS
anti-EphB2 mAb
Eb2Mab-11 (mouse IgM, kappa)
specific for human EphB2 FACS
anti-EphB2 mAb
Eb2Mab-12 (mouse IgG1, kappa)
specific for human EphB2; Kd: 1.7 x 10^-9 for CHO/hEphB2; 4.4 x 10^-10 for LS174T FACS
Back to list

EphB3CharacterApplicationRefGene cloningCompany
anti-EphB3 mAb
Eb3Mab-1 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method; ref: clone 647354 (R&D)
FACS in preparation
(Li et al)
anti-EphB3 mAb
Eb3Mab-2 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
anti-EphB3 mAb
Eb3Mab-3 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
anti-EphB3 mAb
Eb3Mab-4 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
anti-EphB3 mAb
Eb3Mab-5 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
anti-EphB3 mAb
Eb3Mab-6 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
anti-EphB3 mAb
Eb3Mab-7 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
anti-EphB3 mAb
Eb3Mab-9 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
anti-EphB3 mAb
Eb3Mab-10 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
anti-EphB3 mAb
Eb3Mab-11 (mouse IgG1, kappa)
specific for human EphB3
by CBIS method
FACS
Back to list

EphB4CharacterApplicationRefGene cloningCompany
anti-EphB4 mAb (Eb4Mab-1, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
ref: clone ab279601 (abcam)
FACS, WB
anti-EphB4 mAb (Eb4Mab-2, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
FACS
anti-EphB4 mAb (Eb4Mab-3, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
FACS, WB
anti-EphB4 mAb (Eb4Mab-4, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
FACS, WB
anti-EphB4 mAb (Eb4Mab-5, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
FACS, WB
anti-EphB4 mAb (B4Mab-7, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
FACS, WB, IHC B4Mab-7 done
anti-EphB4 mAb (Eb4Mab-8, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
FACS, WB
anti-EphB4 mAb (Eb4Mab-9, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
FACS, WB, IHC
anti-EphB4 mAb (Eb4Mab-10, mouse IgG1, kappa) specific for human EphB4
established by CBIS method
FACS
Back to list

EphB6CharacterApplicationRefGene cloningCompany
anti-EphB6 mAb
Eb6Mab-1 (mouse IgG1,kappa)
specific for human EphB6; established by CBIS method; ref: clone T49-25 (BioLegend; Kd: 1.3 x 10^-8 M for DLD-1; 1.5 x 10^-8 M for CHO/EphB6) FACS
anti-EphB6 mAb
Eb6Mab-2 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
Kd: 8.7 x 10^-9 M for CHO/hEphB6
FACS
anti-EphB6 mAb
Eb6Mab-3 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
Kd: 2.0 x 10^-9 M for DLD-1; 3.8 x 10^-8 M for CHO/EphB6
FACS, WB in preparation (Kaneko et al)
anti-EphB6 mAb
Eb6Mab-4 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method<
3.6 x 10^-9 M for CHO/EphB6
FACS
anti-EphB6 mAb
Eb6Mab-5 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-6 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
3.7 x 10^-9 M for CHO/EphB6
FACS
anti-EphB6 mAb
Eb6Mab-7 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
3.0 x 10^-9 M for CHO/EphB6
FACS
anti-EphB6 mAb
Eb6Mab-8 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
2.5 x 10^-9 M for CHO/EphB6
FACS
anti-EphB6 mAb
Eb6Mab-9 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-10 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-11 (mouse IgM, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-12 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-13 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-14 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-15 (mouse IgG1, lambda)
specific for human EphB6
established by CBIS method
8.4 x 10^-9 M for CHO/EphB6
FACS
anti-EphB6 mAb
Eb6Mab-16 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-17 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-18 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-19 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-20 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS, WB (weak)
anti-EphB6 mAb
Eb6Mab-21 (mouse IgG2b, kappa)
specific for human EphB6
established by CBIS method
7.5 x 10^-8 M for CHO/EphB6
FACS, WB (weak)
anti-EphB6 mAb
Eb6Mab-22 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-23 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
Kd: 3.0 x 10^-8 M for CHO/hEphB6
FACS
anti-EphB6 mAb
Eb6Mab-24 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
Kd: 3.8 x 10^-8 M for CHO/hEphB6
FACS
anti-EphB6 mAb
Eb6Mab-25 (mouse IgG1 or G2b, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-26 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-29 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-30 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
5.8 x 10^-9 M for CHO/EphB6
FACS
anti-EphB6 mAb
Eb6Mab-31 (mouse IgG1, kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-32 (mouse IgG1 (G2b), kappa)
specific for human EphB6
established by CBIS method
FACS
anti-EphB6 mAb
Eb6Mab-33 (mouse IgG1 (G2b), kappa)
specific for human EphB6
established by CBIS method
FACS
Back to list

GM3CharacterApplicationRefGene cloningCompany
anti-GM3 mAb (DH2-mG1, mouse IgG1, kappa) specific for human GM3 FACS DH2 done
Back to the list

GPC1CharacterApplicationRefGene cloningCompany
anti-GPC1 mAb (G1Mab-1, mouse Ig) specific for human GPC1 FACS in preparation
(Yamamoto et al)
anti-GPC1 mAb (G1Mab-2, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-3, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-4, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-5, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-6, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-7, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-8, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-9, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-10, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-11, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-12, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-13, mouse Ig) specific for human GPC1 FACS
anti-GPC1 mAb (G1Mab-14, mouse Ig) specific for human GPC1 FACS
Back to list

GPC2CharacterApplicationRefGene cloningCompany
anti-GPC2 mAb (G2Mab-1, mouse Ig) specific for human GPC2 FACS in preparation
(Ishikawa et al)
Back to list

GPC3CharacterApplicationRefGene cloningCompany
anti-GPC3 mAb
(G3Mab-4; mouse IgM, kappa)
specific for human GPC3 FACS, WB in preparation done
anti-GPC3 mAb
(G3Mab-4-mG1; mouse IgG1, kappa)
specific for human GPC3 FACS, WB done
anti-GPC3 mAb
(G3Mab-4-mG2a; mouse IgG2a, kappa)
specific for human GPC3 FACS, WB done
anti-GPC3 mAb
(humG3Mab-4; human IgG1, kappa)
specific for human GPC3 FACS, WB done
anti-GPC3 mAb
(G3Mab-7; mouse IgG1, kappa)
specific for human GPC3 FACS done
anti-GPC3 mAb
(humG3Mab-7; human IgG1, kappa)
specific for human GPC3 FACS done
Back to list

GPC4CharacterApplicationRefGene cloningCompany
anti-GPC4 mAb (G4Mab-1, mouse Ig) specific for human GPC4 FACS in preparatin
(Li et al)
Back to list

GPC5CharacterApplicationRefGene cloningCompany
anti-GPC5 mAb (G5Mab-1, mouse Ig) specific for human GPC5 FACS in preparatin
(Kaneko et al)
Back to list

GPC6CharacterApplicationRefGene cloningCompany
anti-GPC6 mAb (G6Mab-1, mouse Ig) specific for human GPC6 FACS in preparatin
(Hirose et al)
Back to list

TROP2CharacterApplicationRefGene cloningCompany
anti-TROP2 mAb
(TrMab-6; mouse IgG2b, kappa)
specific for human TROP2; (ref: TNBC) IHC, WB, FACS TrMab-6
MCF7
TNBC
done exbio
anti-TROP2 mAb
(TrMab-29; mouse IgG1, kappa)
specific for human TROP2 IHC, WB, FACS TrMab-29 done merck
anti-TROP2 mAb
(Datopotamab; humanized IgG1, kappa)
Humanized mAb for DS-1062/Dato-DXd (Daiichi-Sankyo) FACS done
anti-TROP2 mAb
(Sacituzumab; humanized IgG1, kappa)
Humanized mAb (Sacituzumab govitecan; Trodelvy) FACS done
Back to list

HGFCharacterApplicationRefGene cloningCompany
anti-HGF mAb
(t8E4; mouse IgG1, kappa)
specific for active HGF WB, IHC SREP
IJMS
done Merck
anti-HGF mAb
(t5A11; mouse IgG1, kappa)
specific for HGF WB, IHC SREP
IJMS
done
anti-HGF mAb
(t1E4; mouse IgG2b, kappa)
specific for HGF neutralization SREP
done
Back to list

PodocalyxinCharacterApplicationRefGene cloningCompany
anti-PODXL mAb
(PcMab-47; mouse IgG1, kappa)
specific for human PODXL FACS, WB, IHC PcMab-47
IHC_OSCC
epitope
done abcam
exbio
anti-PODXL mAb
(47-mG2a; mouse IgG2a, kappa)
IgG2a version of PcMab-47; specific for human PODXL FACS, WB, IHC; ADCC/CDC, antitumor activities 47-mG2a
IHC_LK
IHC_EC
done
anti-PODXL mAb
(47-mG2a-f; mouse IgG2a, kappa)
core fucose-deficient IgG2a version of PcMab-47; specific for human PODXL FACS, WB, IHC; ADCC/CDC, antitumor activities 47-mG2a-f done
anti-PODXL mAb
(chPcMab-47; human IgG1)
specific for human PODXL FACS, WB, IHC chPcMab-47 done
Back to list

human podoplaninCharacterApplicationRefGene cloningCompany
anti-hPDPN mAb (NZ-1; rat IgG2a, lambda)
specific for human PDPN IP, IHC, WB, FACS
(Review; patent)
NZ-1 done Wako
anti-hPDPN mAb (NZ-1.2; rat IgG2a)
specific for human PDPN; the other clones: NZ-1.3(Thermo), NC-08 (BioLegend) IP, IHC, WB, FACS NZ-1.2
done Merck,MBL,Novus, Zenogen,Wako
anti-human PDPN mAb (NZ-8; human IgG1, kappa)
specific for human PDPN; rat-human chimeric mAb originated from NZ-1 IP, IHC, WB, FACS NZ-8 done
anti-human PDPN mAb (NZ-12; human IgG1, lambda)
specific for human PDPN; rat-human chimeric mAb originated from NZ-1 IP, IHC, WB, FACS NZ-12
RIT
done
anti-human PDPN mAb (NZ-16; human IgG1, lambda)
specific for human PDPN; rat-human chimeric mAb originated from NZ-1 IP, IHC, WB, FACS RIT done
anti-human PDPN mAb (NZ-27; human IgG1, lambda)
specific for human PDPN; humanized mAb originated from NZ-1 IP, IHC, WB, FACS NZ-27
CAR-T
done
anti-hPDPN mAb (LpMab-2; mouse IgG1, kappa) CasMab IHC, WB, FACS Cells2022
LpMab-2
patent
done
anti-hPDPN mAb (LpMab-3; mouse IgG1, kappa) specific for human PDPN; epitope: Thr76 IHC, WB, FACS LpMab-3
epitope
Structure
done MCP
anti-hPDPN mAb (LpMab-7 ;mouse IgG1, kappa) specific for human PDPN IHC, WB, FACS LpMab-7
OS
epitope
done abcam
MCP
zenogen
anti-human PDPN mAb (chLpMab-7; human IgG1) specific for human PDPN; mouse-human chimeric mAb originated from LpMab-7 IHC, WB, FACS chLpMab-7 done
anti-hPDPN mAb (LpMab-9; mouse IgG1, kappa) specific for human PDPN; epitope: Thr25 WB, FACS LpMab-9
epitope
done MCP
anti-hPDPN mAb (LpMab-10; mouse IgG3, kappa) specific for human PDPN; epitope: PLAG1 Thr34 IHC, WB, FACS LpMab-10 done
anti-hPDPN mAb (LpMab-12; mouse IgG1, kappa) specific for human PDPN; epitope: PLAG3 Thr52 IHC, WB, FACS LpMab-12 done CST Merck
Hycult
MCP, zenogen
anti-hPDPN mAb (LpMab-13; mouse IgG1, kappa) specific for human PDPN; epitope: PLAG2-3 IHC, WB, FACS LpMab-13 done Merck
Hycult
anti-hPDPN mAb (LpMab-16; mouse IgG1, kappa) specific for human PDPN IHC, WB, FACS patent 2018-123699 done
anti-hPDPN mAb (LpMab-17; mouse IgG1, kappa) specific for human PDPN IHC, WB, FACS
press release
LpMab-17 done BD
Merck
Hycult
anti-hPDPN mAb (LpMab-19; mouse IgG2b, kappa) specific for human PDPN; epitope: Thr76 IHC, WB, FACS, ADCC/CDC LpMab-19 done Merck
anti-hPDPN mAb (LpMab-21; mouse IgG2a, kappa) specific for human PDPN; epitope: Thr76 IHC, WB, FACS, ADCC/CDC
press release
Cells2022
LpMab-21
in vivo
done Merck
BioLegend
MCP
anti-hPDPN mAb (LpMab-23; mouse IgG1, kappa) CasMab IHC, WB, FACS LpMab-23
IHC
patent
done BD
exbio
zenogen
Back to list

mouse podoplaninCharacterApplicationRefGene cloningCompany
anti mouse PDPN mAb (PMab-1; rat IgG2a, kappa)
specific for mouse PDPN
--> anti-human PDPN
IHC, WB, FACS PMab-1
PMab-1_LEC
epitope
done abcam; MBL; Nov; Mer; BioL; BD
anti-mouse PDPN mAb (mPMab-1; mouse IgG2a,kappa) specific for mouse PDPN IHC, WB, FACS mPMab-1
done
anti-mouse PDPN mAb (PMab-1-mG2a-f; mouse IgG2a,kappa) specific for mouse PDPN IHC, WB, FACS done
rat podoplaninCharacterApplicationRefGene cloningCompany
anti-rat PDPN mAb
(PMab-2; mouse IgG1, kappa)
specific for rat PDPN IHC, WB, FACS PMab-2
PMab-2_epitope
done abcam
Merck
BioLegend
rabbit podoplaninCharacterApplicationRefGene cloningCompany
anti-rabbit PDPN mAb
(PMab-32; mouse IgG1, kappa)
specific for rabbit PDPN IHC, WB, FACS PMab-32
epitope
dog podoplaninCharacterApplicationRefGene cloningCompany
anti-dog PDPN mAb
(PMab-38; mouse IgG1, kappa)
specific for dog PDPN IHC, WB, FACS PMab-38; SCC
melanoma
epitope
done zenogen
Wako
anti-dog PDPN mAb
(P38Bf; dog IgGB, kappa)
core fucose-deficient type B of PMab-38 IHC, WB, FACS P38Bf
P38B_in vivo
ADC
done
anti-dog PDPN mAb
(PMab-48; mouse IgG1, kappa)
specific for dog PDPN IHC, WB, FACS PMab-48
epitope
done zenogen
bovine podoplaninCharacterApplicationRefGene cloningCompany
anti-bovPDPN mAb (PMab-44; mouse IgG1, kappa) specific for bovine PDPN IHC, WB, FACS PMab-44; epitope
goat; sheep; alpaca
done zenogen
cat podoplaninCharacterApplicationRefGene cloningCompany
anti-cat PDPN mAb
(PMab-52; mouse IgM, kappa)
specific for cat PDPN IHC, WB, FACS PMab-52; epitope
IHC-1; IHC-2
tiger PDPN
done zenogen
tiger podoplaninCharacterApplicationRefGene cloningCompany
anti-tiger PDPN mAb
(PMab-231; mouse IgG2a, kappa)
specific for tiger PDPN IHC, WB, FACS PMab-231
epitope; lion
done zenogen
tiger podoplaninCharacterApplicationRefGene cloningCompany
anti-tiger PDPN mAb
(PMab-231-f; mouse IgG2a, kappa)
defucosylation of PMab-231 isotype control of
mouse IgG2a in vivo
250_in vivo done zenogen
horse podoplaninCharacterApplicationRefGene cloningCompany
anti-horse PDPN mAb
(PMab-219; mouse IgG2a, kappa)
specific for horse PDPN WB, FACS, IHC PMab-219
epitope
done zenogen
anti-horse PDPN mAb
(PMab-202; mouse IgG1, kappa)
specific for horse PDPN WB, FACS PMab-202
epitope
done zenogen
pig podoplaninCharacterApplicationRefGene cloningCompany
anti-pig PDPN mAb
(PMab-213; mouse IgG2b, kappa)
specific for pig PDPN WB, FACS, IHC PMab-213
epitope
LEC
done zenogen
anti-pig PDPN mAb
(PMab-210; mouse IgG1, kappa)
specific for pig PDPN WB, FACS, IHC PMab-210
epitope
done zenogen
goat podoplaninCharacterApplicationRefGene cloningCompany
anti-goat PDPN mAb (PMab-235; mouse IgG1, kappa) specific for goat PDPN IHC, WB, FACS PMab-235
epitope
done zenogen
alpaca podoplaninCharacterApplicationRefGene cloningCompany
anti-aPDPN mAb (PMab-225; mouse IgG2b, kappa) specific for alpaca PDPN IHC, WB, FACS PMab-225
epitope
done zenogen
Tas_devil podoplaninCharacterApplicationRefGene cloningCompany
anti-TasPDPN PDPN (PMab-233; mouse IgG1, kappa) specific for Tasmanian devil PDPN IHC, WB, FACS PMab-233
epitope
done zenogen
bear podoplaninCharacterApplicationRefGene cloningCompany
anti-bear PDPN mAb
(PMab-241; mouse IgG2b, kappa)
specific for bear PDPN IHC, WB, FACS PMab-241
epitope
anti-bear PDPN mAb
(PMab-247; mouse IgG1, kappa)
specific for bear PDPN IHC, WB, FACS PMab-247
IHC
epitope
done zenogen
whale podoplaninCharacterApplicationRefGene cloningCompany
anti-whale PDPN mAb
(PMab-237; mouse IgG1, kappa)
specific for whale PDPN IHC, WB, FACS PMab-237
IHC
epitope
done zenogen
sheep podoplaninCharacterApplicationRefGene cloningCompany
anti-sheep PDPN mAb
(PMab-256; mouse IgG1, kappa)
specific for sheep PDPN IHC, WB, FACS PMab-256
epitope
done zenogen
anti-sheep PDPN mAb
(PMab-253; mouse IgM, kappa)
specific for sheept PDPN IHC, WB, FACS PMab-253 done
anti-sheep PDPN mAb
(PMab-260; mouse IgM, kappa)
specific for sheep PDPN IHC, WB, FACS PMab-260 done
sea lion podoplaninCharacterApplicationRefGene cloningCompany
anti-seaPDPN mAb (PMab-269; mouse IgG1, kappa) specific for sea lion PDPN IHC, WB, FACS PMab-269
epitope
Steller Sea Lion
done
elephant podoplaninCharacterApplicationRefGene cloningCompany
anti-elePDPN mAb (PMab-265; mouse IgM, kappa) specific for elephant PDPN FACS PMab-265
anti-elePDPN mAb (PMab-295; mouse IgG1, kappa) specific for elephant PDPN FACS, WB, IHC PMab-295
epitope
done Ab.antibody
ferret podoplaninCharacterApplicationRefGene cloningCompany
anti-ferret PDPN mAb
(PMab-241; mouse IgG2b, kappa)
anti-bear PDPN mAb crossreacts with ferret PDPN IHC, WB, FACS PMab-241
anti-ferret PDPN mAb
(PMab-292; mouse IgG1, kappa)
specific for ferret PDPN IHC, WB, FACS PMab-292
epitope
done Ab.antibody
anti-ferret PDPN mAb
(PMab-293; mouse IgM, kappa)
specific for ferret PDPN FACS, WB
hamster podoplaninCharacterApplicationRefGene cloningCompany
anti-hamPDPN mAb (PMab-281; mouse IgG3, kappa) specific for hamster PDPN FACS, IHC PMab-281
epitope
done
anti-hamPDPN mAb (281-mG2a; mouse IgG2a, kappa) specific for hamster PDPN; IgG2a version of PMab-281 FACS, IHC 281-mG2a
epitope
done
anti-hamPDPN mAb (281-mG2a-f; mouse IgG2a, kappa) defucocylated 281-mG2a isotype control of
mouse IgG2a in vivo
H2Mab-214
H2Mab-77
done
giraffe podoplaninCharacterApplicationRefGene cloningCompany
anti-girPDPN mAb (PMab-301; mouse IgG1, kappa) specific for giraffe PDPN
Kd: 1.3 x 10-8 M
FACS, WB, IHC PMab-301
panda podoplaninCharacterApplicationRefGene cloningCompany
anti-panPDPN mAb (PMab-314; mouse IgG1, kappa) specific for panda PDPN
Kd: 1.3 x 10-8 M
FACS, WB PMab-314
hippopotamus podoplaninCharacterApplicationRefGene cloningCompany
anti-hipPDPN mAb (PMab-***; mouse IgG) specific for hippopotamus PDPN
rhinoceros podoplaninCharacterApplicationRefGene cloningCompany
anti-rhiPDPN mAb (PMab-***; mouse IgG) specific for rhinoceros PDPN
Back to list



intracellular proteins
ATRXCharacterApplicationRefGene cloningCompany
anti-ATRX mAb
(AMab-6; mouse IgG1, kappa)
specific for human ATRX IHC, WB AMab-6
AMab-6_epitope
AMab-6_IHC
done abcam
Back to the list

DGKCharacterApplicationRefGene cloningCompany
anti-DGKalpha mAb
(DaMab-2; mouse IgG1, kappa)
specifi for DGKalpha ICC DaMab-2
epitope
done
anti-DGKalpha mAb
(Da2mG2a; mouse IgG2a, kappa)
specifi for DGKalpha ICC done
anti-DGKalpha mAb
(DaMab-8; mouse IgG1, kappa)
specific for DGKalpha IHC DaMab-8

done
anti-DGKalpha mAb
(Da8mG2a;
mouse IgG2a, kappa)
specific for DGKalpha ICC, IHC
done
anti-DGKgamma mAb
(DgMab-6; mouse IgG1, kappa)
specific for DGKgamma ICC DgMab-6
PDF
done
anti-DGKalpha mAb
(Dg6mG2a; mouse IgG2a, kappa)
specifi for DGKgamma ICC done
anti-DGKzeta mAb
(DzMab-1; rat IgG2b, kappa)
specific for DGKzeta ICC DzMab-1
epitope
done
anti-DGKzeta mAb
(Dz1mG2a;
mouse IgG2a, kappa)
specific for DGKzeta ICC done
anti-DGKeta mAb
(DhMab-1;mouse IgG2c, kappa)
specific for DGKeta IHC DhMab-1 done
anti-DGKalpha mAb
(Dh1mG2a; mouse IgG2a, kappa)
specifi for DGKeata ICC done
anti-DGKeata mAb
(DhMab-4; mouse IgG2b, kappa)
specific for DGKeta IHC DhMab-4
ICC
done
anti-DGKalpha mAb
(Dh4mG2a; mouse IgG2a, kappa)
specifi for DGKeata ICC done
anti-DGKdelta mAb
(DdMab-1; mouse IgG2c, kappa)
specific for DGKdeta IHC DdMab-1 done
anti-DGKalpha mAb
(Dd1mG2a; mouse IgG2a, kappa)
specifi for DGKdelta ICC done
Back to list

IDHCharacterApplicationRefGene cloningCompany
anti-IDH1-R132H mAb (HMab-1; mouse IgG1, kappa) specific for IDH1-R132H IHC, WB HMab-1 done Merck
MBL; IBL; Sigma
anti-IDH1-R132H mAb (HMab-2; mouse IgG1, kappa) specific for IDH1-R132H IHC, WB HMab-2 done abcam
anti-IDH1-R132S mAb (SMab-1; mouse IgG1, kappa) specific for IDH1-R132S IHC, WB SMab-1 done abcam
IBL; MBL
Merck_Sigma
anti-IDH1-R132G mAb (GMab-r1; rat IgG2a, kappa) specific for IDH1-R132G IHC, WB GMab-r1 done abcam
MBL
anti-IDH2-R172K mAb (KMab-1; rat IgG2b, kappa) specific for IDH2-R172K IHC, WB
isotype control
of rat IgG2b
KMab-1 done abcam
MBL
anti-IDH2-R172M mAb (MMab-1; rat IgG2b, kappa) specific for IDH2-R172M IHC, WB MMab-1 done abcam
anti-IDH2-R172W mAb (WMab-1; rat IgG2b, kappa) specific for IDH2-R172W IHC, WB WMab-1 done abcam
MBL
anti-IDH2-R172S mAb (SMab-2; mouse IgG1, kappa) specific for IDH2-R172S IHC, WB SMab-2 abcam
anti-IDH1 mAb (RMab-3; mouse IgG1, kappa) specific for IDH1 IHC, WB RMab-3 BD
MBL
anti-IDH1 mAb(RcMab-1; rat IgG2a, kappa) specific for IDH1 IHC, WB
isotype control
of rat IgG2a
RcMab-1 done abcam
CST
MBL
anti-IDH2 mAb (RMab-22; mouse IgG2b, kappa) specific for IDH2 IHC, WB RMab-22 MBL
anti-IDH2 mAb (KrMab-3; mouse IgG2b, kappa) specific for IDH2 IHC, WB KrMab-3 CST
BioLegend
MBL
anti-mIDH1/2 mAb (MsMab-1; mouse IgG1, kappa) specific for mutated IDH1/2 IHC, WB
(ref)
TJEM
Brain Tumor Pathol
Cancer Med
done abcam
Merck
anti-mIDH1/2 mAb (MsMab-2; rat IgG2a, kappa) specific for mutated IDH1/2 IHC, WB MsMab-2 done MBL
Back to list

TERTCharacterApplicationRefGene cloningCompany
anti-mTERT mAb
(TmMab-1; rat IgG1, kappa)
specific for mTERT ELISA, WB
isotype control
of rat IgG1
done
anti-mTERT mAb
(TmMab-2; rat IgG2a, kappa)
specific for mTERT ELISA
isotype control
of rat IgG2a
done
anti-mTERT mAb
(TmMab-3; rat IgG1, kappa)
specific for mTERT ELISA, WB done
anti-mTERT mAb
(TmMab-4; rat IgG1, kappa)
specific for mTERT ELISA done
anti-hTERT mAb
(TpMab-1; mouse IgG1, kappa)
specific for phosphorylated threonine 249 of hTERT IHC, WB, ELISA TpMab-1 (press)
NCB
done
anti-hTERT mAb
(TpMab-2; mouse IgG1, kappa)
specific for phosphorylated threonine 249 of hTERT IHC, WB, ELISA done
anti-hTERT mAb
(TpMab-3; mouse IgG1, kappa)
specific for phosphorylated threonine 249 of hTERT IHC, WB, ELISA TpMab-3 (press)
NCB
done Merck
anti-hTERT mAb
(TpMab-35; mouse IgG1, kappa)
specific for phosphorylated threonine 249 of hTERT ICC, WB, ELISA TpMab-35
anti-hTERT mAb
(TwMab-1; mouse IgG1, kappa)
specific for hTERT IHC, WB, ELISA TwMab-1 done Merck
anti-hTERT mAb
(TMab-6; mouse IgM, kappa)
specific for hTERT IHC TMab-6
TMab-6_epitope
done
Back to list



Monoclonal antibodies for SARS-CoV-2
SARS-CoV-2
(S1 RBD)
CharacterApplicationRefGene cloningCompany
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-1; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 319-338 aa
RBD: Receptor binding domain
ELISA,WB, IHC done
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-2; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 459-478 aa
ELISA, WB, IHC, neutralization
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-3; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 469-478 aa
ELISA,WB, IHC, neutralization
anti SARS-CoV-2 S1-RBD mAb
(CvMab-6; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 459-478 aa
ELISA, WB, IHC, neutralization CvMab-6 done
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-7; mouse IgM, kappa)
specific for SARS-CoV-2 S1-RBD
epitope:459-478 aa
ELISA, WB, IHC, neutralization done
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-13; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 459-478 aa
ELISA, WB, IHC done
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-17; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 459-478 aa
ELISA, WB, neutralization, IHC
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-18; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 459-478 aa
ELISA, WB, neutralization, IHC
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-24; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 459-478 aa
ELISA, WB, IHC, neutralization
anti-SARS-CoV-2 S1-RBD mAb
(CvMab-25; mouse IgG1, kappa)
specific for SARS-CoV-2 S1-RBD
epitope: 459-478 aa
ELISA, IHC, WB
Back to list

SARS-CoV-2
(S1 N terminus)
CharacterApplicationRefGene cloningCompany
anti-SARS-CoV-2 mAb
(CvMab-32; mouse IgG2b, kappa)
specific for SARS-CoV-2 S1N terminus ELISA, IHC, WB
Back to list

SARS-CoV-2
(S2)
CharacterApplicationRefGene cloningCompany
anti-SARS-CoV-2 mAb
(CvMab-36; mouse IgG1, kappa)
specific for SARS-CoV-2 S2 ELISA, WB
anti-SARS-CoV-2 mAb
(CvMab-62; mouse IgG1, kappa)
specific for SARS-CoV-2 S2 ELISA
isotype control
of mouse IgG1
CvMab-62 done
anti-SARS-CoV-2 mAb
(CvMab-6-Fab; mouse Fab, kappa)
specific for SARS-CoV-2 S2 ELISA done
anti-SARS-CoV-2 mAb
(humCvMab-62; human IgG1, kappa)
specific for SARS-CoV-2 S2 ELISA
isotype control
of human IgG1
done
Back to list

SARS-CoV-2
(bi-specific)
CharacterApplicationRefGene cloningCompany
anti-SARS-CoV-2 mAb
(CvMab-bis1)
specific for SARS-CoV-2 S1+S2
bispecific mAb
CvMab-6-H_CvM62scFv
CvMab-bis1 done
anti-SARS-CoV-2 mAb
(CvMab-bis2)
specific for SARS-CoV-2 S1+S2
bispecific mAb
CvMab-6-L_CvM62scFv
CvMab-bis2 done
anti-SARS-CoV-2 mAb
(CvMab-bis3)
specific for SARS-CoV-2 S1+S2
bispecific mAb
CvMab-62-H_CvM6scFv
CvMab-bis3 done
anti-SARS-CoV-2 mAb
(CvMab-bis4)
specific for SARS-CoV-2 S1+S2
bispecific mAb
CvMab-62-L_CvM6scFv
CvMab-bis4 done
CvMab-62-H_Bebtelovimab-scFv
(bispecific)
specific for SARS-CoV-2 S1+S2 Bebtelovimab done
humCvMab-62-H_Bebtelovimab-scFv
(bispecific)
specific for SARS-CoV-2 S1+S2 Bebtelovimab done
CvMab-62-H_Cilgavimab-scFv
(bispecific)
specific for SARS-CoV-2 S1+S2 done
Back to list

SARS-CoV-2
(humanized)
CharacterApplicationRefGene cloningCompany
Bebtelovimab
(human IgG1, lambda)
specific for SARS-CoV-2 S1
(sequence) (Lancet)
Neutralization; weak activity for all variants Bebtelovimab done
Cilgavimab
(human IgG1, kappa)
specific for SARS-CoV-2 S1
(sequence) (Lancet)
Cilgavimab plus tixagevimab (EVUSHELD)
Neutralization; weak activity for BA.2; resistant for BA.4/5 done
Casirivimab
(human IgG1, kappa)
specific for SARS-CoV-2 S1
(sequence) (Lancet)
Casirivimab plus imdevimab (Ronapreve)
Neutralization; weak activity for Omicron done
Bamlanivimab
(human IgG1, kappa)
specific for SARS-CoV-2 S1
(sequence) (Lancet)
Neutralization; no activity for Omicron done
Bebtelovimab-scFv
(scFv-Fc of human IgG1)
specific for SARS-CoV-2 S1 Bebtelovimab done
Cilgavimab-scFv
(scFv-Fc of human IgG1)
specific for SARS-CoV-2 S1 done
Back to list

RdRPCharacterApplicationRefGene cloningCompany
anti-RdRP mAb
(RdMab-2; mouse IgG2a, kappa)
specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC; distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV ELISA, WB, IP, ICC RdMab-2 done
anti-RdRP mAb
(RdMab-13; mouse IgM, kappa)
specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC;
distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV
ELISA, WB
isotype control
of mouse IgM
RdMab-13
anti-RdRP mAb
(RdMab-15; mouse IgG1, kappa)
specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP
; Immunogen: RHTFSNYQHEETIYNLLKDC
ELISA, WB RdMab-15
anti-RdRP mAb
(RdMab-16; mouse IgG1, kappa)
specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP
; Immunogen: RHTFSNYQHEETIYNLLKDC
ELISA, WB RdMab-16
anti-RdRP mAb
(RdMab-20; mouse IgG2b, kappa)
specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC;
distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV
ELISA, WB
isotype control
of mouse IgG2b
RdMab-20
Back to list



anti-dog protein monoclonal antibodies
dog PDPNCharacterApplicationRefGene cloningCompany
anti-dog PDPN mAb
(PMab-38; mouse IgG1, kappa)
specific for dog PDPN IHC, WB, FACS PMab-38; SCC
melanoma
epitope
done zenogen
Wako
anti-dog PDPN mAb
(P38Bf; dog IgGB, kappa)
core fucose-deficient type B of PMab-38 IHC, WB, FACS P38Bf
P38B_in vivo
ADC
done
anti-dog PDPN mAb
(PMab-48; mouse IgG1, kappa)
specific for dog PDPN IHC, WB, FACS PMab-48
epitope
done zenogen
dog EGFRCharacterApplicationRefGene cloningCompany
anti-EGFR mAb
(134-mG2a-f; mouse IgG2a, kappa)
core fucose-deficient mouse IgG2a version of EMab-134; reacts with domain-III FACS, WB, IHC, ADCC, CDC, antitumor activities CHO/dEGFR
Osteosarcoma
Fibroblastic
Mammary
done
anti-EGFR mAb
(E134Bf; canine IgGB, kappa)
core fucose-deficient canine IgGB version of EMab-134; specific for EGFR FACS, WB, IHC, ADCC, CDC, antitumor activities Mammary
Fibro & Osteo
done
dog HER2CharacterApplicationRefGene cloningCompany
anti-HER2 mAb
(H77Bf; canine IgGB, kappa)
core fucose-deficient canine IgGB version of H2Mab-77 FACS, WB, IHC, ADCC/CDC, antitumor activities H77Bf
OS
fibro
done
anti-HER2 mAb
(H2Mab-41; mouse IgG2b, kappa)
specific for HER2; crossreacts with dog HER2; domain-IV FACS, antitumor activities H2Mab-41 dogHER2
done
EGFR-HER2
(bispecific)
CharacterApplicationRefGene cloningCompany
anti-dog EGFR-dog HER2 mAb
(E134B-H77scFv-f)
bispecific mAb for EGFR and HER2 FACS, WB, IHC, ADCC, CDC, antitumor activities E134B-H77scFv-f done
dog PD-L1
CharacterApplicationRefGene cloningCompany
anti-dog PD-L1 mAb
(L1Mab-347; mouse IgG1, kappa)
specific for dog PD-L1 FACS, IHC done
anti-dog PD-L1 mAb
(L1Mab-348;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA
anti-dog PD-L1 mAb
(L1Mab-349;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA
anti-dog PD-L1 mAb
(L1Mab-350;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA
anti-dog PD-L1 mAb
(L1Mab-351;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA
anti-dog PD-L1 mAb
(L1Mab-352;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA, IHC L1Mab-352 done
anti-dog PD-L1 mAb
(L1Mab-353;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA
anti-dog PD-L1 mAb
(L1Mab-354;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA, IHC L1Mab-354 done
anti-dog PD-L1 mAb
(L1Mab-355;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA
anti-dog PD-L1 mAb
(L1Mab-356;
mouse IgG1, kappa)
specific for dog PD-L1 (intracellular domain) ELISA
Back to list



CasMab
PDPNCharacterApplicationRefGene cloningCompany
anti-hPDPN mAb (LpMab-2; mouse IgG1, kappa) CasMab; patent IHC, WB, FACS PDPN_review
LpMab-2
done zenogen
anti-human PDPN mAb(chLpMab-2; human IgG1, kappa)
CasMab for human PDPN; mouse-human chimeric mAb originated from LpMab-2 IP, IHC, WB, FACS chLpMab-2 done zenogen
anti-hPDPN mAb (LpMab-2-scFv;
scFv)
CasMab for human PDPN;
scFv originated from LpMab-2
CART CART done
anti-hPDPN mAb (LpMab-23; mouse IgG1, kappa) CasMab IHC, WB, FACS LpMab-23
IHC
patent
done BD
exbio
zenogen
anti-human PDPN mAb (chLpMab-23; human IgG1) CasMab for human PDPN; mouse-human chimeric mAb originated from LpMab-23 IHC, WB, FACS chLpMab-23 done zenogen
anti-human PDPN mAb (humLpMab-23-f; human IgG1) CasMab for human PDPN; humanized mAb originated from LpMab-23 IHC, WB, FACS humLpMab-23-f done zenogen
anti-hPDPN mAb (humLpMab-23-scFv) CasMab for human PDPN;
scFv originated from LpMab-23
CART in preparation done
anti-hPDPN mAb (PMab-117; rat IgM, kappa) CasMab FACS Cells2022
patent
done zenogen
Back to list

PodocalyxinCharacterApplicationRefGene cloningCompany
anti-PODXL mAb
(PcMab-6; mouse IgG1, kappa)
anti-PODXL CasMab FACS PcMab-6
patent
done zenogen
anti-PODXL mAb
(PcMab-6-mG2a-f; mouse IgG2a)
anti-PODXL CasMab; IgG2a version of PcMab-6 FACS, ADCC/CDC PcMab-6-mG2a-f done zenogen
anti-PODXL mAb
(PcMab-6-hG1-f; human IgG1)
anti-PODXL CasMab; human IgG1 version of PcMab-6 FACS, ADCC/CDC done zenogen
anti-PODXL mAb
(humPcMab-6-f; human IgG1)
CasMab for PODXL; humanized mAb originated from PcMab-6 FACS humPcMab-6-f done zenogen
anti-hPDPN mAb (humPcMab-6-scFv; scFv) CasMab; scFv originated from PcMab-6 CART in preparation done
anti-PODXL mAb
(PcMab-60; mouse IgM, kappa)
anti-PODXL CasMab FACS PcMab-60
epitope
patent
done zenogen
anti-PODXL mAb
(60-mG2a; mouse IgG2a, kappa)
anti-PODXL CasMab; IgG2a version of PcMab-60 FACS, ADCC/CDC 60-mG2a done zenogen
anti-PODXL mAb
(60-mG2a-f; mouse IgG2a, kappa)
anti-PODXL CasMab, core fucose-deficient IgG2a version of PcMab-60 FACS, ADCC/CDC, antitumor activities 60-mG2a-f done zenogen
anti-PODXL mAb
(PcMab-60-hG1-f; human IgG1)
anti-PODXL CasMab; human IgG1 version of PcMab-60 FACS, ADCC/CDC done zenogen
anti-PODXL mAb
(humPcMab-60; human IgG1)
anti-PODXL CasMab; humanized PcMab-60 FACS, ADCC/CDC done zenogen
anti-hPDPN mAb (humPcMab-60-scFv; scFv) CasMab; scFv originated from PcMab-60 CART done
Back to list

CD44sCharacterApplicationRefGene cloningCompany
anti-CD44s mAb
(C44Mab-1012;
mouse IgM, kappa)
Mab1 for CD44s (exon-6)
cossreact with mouse CD44
FACS done
anti-CD44s mAb
(C44Mab-1012-mG1; mouse IgG1)
Mab1 for CD44s (exon-6) FACS done
anti-CD44s mAb
(C44Mab-1012-hG1; human IgG1)
Mab1 for CD44s (exon-6) FACS done
anti-CD44s mAb
(C44Mab-1075;
mouse IgG2a, kappa)
Mab2 for CD44s (exon-6) FACS done
anti-CD44s mAb
(C44Mab-1095;
mouse IgG1, kappa)
Mab3 for CD44s (exon-6) FACS done
Back to list

CD44v3CharacterApplicationRefGene cloningCompany
anti-CD44v3 mAb
(C44Mab-1080;
mouse IgG1, kappa)
Mab6 for CD44v3 FACS, WB, IHC done
anti-CD44v3 mAb
(C44Mab-1006;
mouse IgG1, kappa)
Mab11 for CD44v3 FACS, WB, IHC done
CD44v5CharacterApplicationRefGene cloningCompany
anti-CD44v5 mAb
(C44Mab-1088;
mouse IgG1, kappa)
Mab8 for CD44v5 FACS, WB, IHC done
anti-CD44v5 mAb
(C44Mab-1003;
mouse IgG1, kappa)
Mab12 for CD44v5 FACS, WB, IHC done
CD44v6CharacterApplicationRefGene cloningCompany
anti-CD44v6 mAb
(C44Mab-1081;
mouse IgG1, kappa)
Mab7 for CD44v6 FACS, WB, IHC done
anti-CD44v6 mAb
(C44Mab-1089;
mouse IgM, kappa)
Mab9 for CD44v6 FACS, WB, IHC done
anti-CD44v6 mAb
(C44Mab-1089-mG1;
mouse IgG1, kappa)
Mab9 for CD44v6 FACS, WB, IHC
anti-CD44v6 mAb
(C44Mab-1074;
mouse IgM, kappa)
Mab14 for CD44v6 FACS, WB, IHC done
anti-CD44v6 mAb
(C44Mab-1074-mG1;
mouse IgG1, kappa)
Mab14 for CD44v6 FACS, WB, IHC
anti-CD44v6 mAb
(C44Mab-1079;
mouse IgG1, kappa)
Mab15 for CD44v6 FACS, WB, IHC done
anti-CD44v6 mAb
(C44Mab-1092;
mouse IgG3, kappa)
Mab16 for CD44v6 FACS, WB, IHC done
anti-CD44v6 mAb
(C44Mab-1092-mG1;
mouse IgG1, kappa)
Mab16 for CD44v6 FACS, WB, IHC
CD44v7CharacterApplicationRefGene cloningCompany
anti-CD44v7 mAb
(C44Mab-1030;
mouse IgM, kappa)
Mab4 for CD44v7 FACS, WB, IHC done
anti-CD44v7 mAb
(C44Mab-1048;
mouse IgG1, kappa)
Mab5 for CD44v7 FACS, WB, IHC done
anti-CD44v7 mAb
(C44Mab-1034;
mouse IgG1, kappa)
Mab10 for CD44v7 FACS, WB, IHC done
Back to list

EpCAM CharacterApplicationRefGene cloningCompany
anti-EpCAM mAb
(EpMab-1123; mouse IgM, kappa)
Mab1 for EpCAM FACS x
anti-EpCAM mAb
(EpMab-1138; mouse IgM, kappa)
Mab2 for EpCAM FACS x
anti-EpCAM mAb
(EpMab-1147; mouse IgG1, kappa)
Mab3 for EpCAM FACS done
anti-EpCAM mAb
(EpMab-1007; mouse IgG1, kappa)
Mab4 for EpCAM FACS done
anti-EpCAM mAb
(EpMab-1013; mouse IgG1, kappa)
Mab5 for EpCAM FACS done
anti-EpCAM mAb
(EpMab-1022; mouse IgG1, kappa)
Mab6 for EpCAM FACS done
anti-EpCAM mAb
(EpMab-1069; mouse IgG1, kappa)
Mab7 for EpCAM FACS done
Back to list

TROP2CharacterApplicationRefGene cloningCompany
anti-TROP2 mAb
(TrMab-1100; mouse IgG1, kappa)
Mab1 for human TROP2 FACS done
anti-TROP2 mAb
(TrMab-1148; mouse IgG1, kappa)
Mab3 for human TROP2 FACS done
anti-TROP2 mAb
(TrMab-1156; mouse IgG2b, kappa)
Mab4 for human TROP2 FACS done
Back to list

HER2CharacterApplicationRefGene cloningCompany
anti-HER2 mAb
(H2Mab-250;
mouse IgG1,kappa)
H2CasMab-2; specific for HER2; domain-IV FACS, WB, IHC H2Mab-250
250_in vivo
done
anti-HER2 mAb
(H2Mab-250-mG2af; mouse IgG2a,kappa)
H2CasMab-2; specific for HER2; domain-IV FACS, WB, IHC H2Mab-250
250_in vivo
done
anti-HER2 mAb
(H2Mab-250-hG1-f; human IgG1,kappa)
H2CasMab-2; specific for HER2; domain-IV FACS, WB, IHC 250_in vivo done
anti-HER2 mAb
(H2Mab-250-scFv)
H2CasMab-2;
specific for HER2;
domain-IV
CART FT825 done
Back to list

HER3CharacterApplicationRefGene cloningCompany
anti HER3 mAb
(H3Mab-1059;
mouse IgG1,kappa)
Mab1 for HER3 FACS done
anti HER3 mAb
(H3Mab-1170;
mouse IgG1,kappa)
Mab2 for HER3 FACS done
Back to list

CAR-T
CD19CharacterApplicationRefGene cloningCompany
anti-CD19 mAb (C19Mab-2; mouse IgG1,kappa) specific for CD19; CBIS method; LN229/CD19 immunization FACS done
anti-CD19 mAb (humC19Mab-2; human IgG1,kappa) humanized C19Mab-2 FACS done
anti-CD19 mAb (humC19Mab-2
-scFv)
scFv of humanized C19Mab-2 FACS done
Back to list

GPC3CharacterApplicationRefGene cloningCompany
anti-GPC3 mAb
(G3Mab-1; mouse IgG1, kappa)
specific for human GPC3
ref: abcam
FACS done
anti-GPC3 mAb
(humG3Mab-1; human IgG1, kappa)
specific for human GPC3 FACS done
anti-GPC3 mAb
(humG3Mab-1-scFv)
specific for human GPC3 CAR-T done
anti-GPC3 mAb
(G3Mab-2; mouse IgM, kappa)
specific for human GPC3 FACS, WB done
anti-GPC3 mAb
(humG3Mab-2; human IgG1, kappa)
specific for human GPC3 FACS done
anti-GPC3 mAb
(humG3Mab-2-scFv-Fc)
specific for human GPC3 CAR-T done
anti-GPC3 mAb
(G3Mab-3; mouse IgM, kappa)
specific for human GPC3 FACS, WB done
anti-GPC3 mAb
(humG3Mab-3; human IgG1, kappa)
specific for human GPC3 FACS done
anti-GPC3 mAb
(humG3Mab-3-scFv-Fc)
specific for human GPC3 CAR-T done
Back to list

HER2CharacterApplicationRefGene cloningCompany
anti-HER2 mAb
(H2Mab-250;
mouse IgG1,kappa)
H2CasMab-2; specific for HER2; domain-IV FACS, WB, IHC H2Mab-250
250_in vivo
done
anti-HER2 mAb
(H2Mab-250-mG2af; mouse IgG2a,kappa)
H2CasMab-2; specific for HER2; domain-IV FACS, WB, IHC H2Mab-250
250_in vivo
done
anti-HER2 mAb
(H2Mab-250-hG1-f; human IgG1,kappa)
H2CasMab-2; specific for HER2; domain-IV FACS, WB, IHC 250_in vivo done
anti-HER2 mAb
(H2Mab-250-scFv)
H2CasMab-2;
specific for HER2;
domain-IV
CART FT825 done
Back to list

PDPNCharacterApplicationRefGene cloningCompany
anti-hPDPN mAb (LpMab-23; mouse IgG1, kappa) CasMab IHC, WB, FACS LpMab-23
IHC
patent
done BD
exbio
zenogen
anti-human PDPN mAb (chLpMab-23; human IgG1) CasMab for human PDPN; mouse-human chimeric mAb originated from LpMab-23 IHC, WB, FACS chLpMab-23 done zenogen
anti-human PDPN mAb (humLpMab-23-f; human IgG1) CasMab for human PDPN; humanized mAb originated from LpMab-23 IHC, WB, FACS humLpMab-23-f done zenogen
anti-hPDPN mAb (humLpMab-23-scFv) CasMab for human PDPN;
scFv originated from LpMab-23
CART in preparation done
anti-hPDPN mAb (PMab-117; rat IgM, kappa) CasMab FACS Cells2022
patent
done zenogen
anti-human PDPN mAb (chPMab-117; human IgG1) CasMab for human PDPN; mouse-human chimeric mAb originated from PMab-117 FACS done zenogen
anti-human PDPN mAb (humPMab-117-f; human IgG1) CasMab for human PDPN; humanized mAb originated from PMab-117 FACS done zenogen
anti-hPDPN mAb (humPMab-117-scFv) CasMab for human PDPN;
scFv originated from PMab-117
CART done
Back to list

PodocalyxinCharacterApplicationRefGene cloningCompany
anti-PODXL mAb
(PcMab-6; mouse IgG1, kappa)
anti-PODXL CasMab FACS PcMab-6
patent
done zenogen
anti-PODXL mAb
(PcMab-6-mG2a-f; mouse IgG2a)
anti-PODXL CasMab; IgG2a version of PcMab-6 FACS, ADCC/CDC PcMab-6-mG2a-f done zenogen
anti-PODXL mAb
(PcMab-6-hG1-f; human IgG1)
anti-PODXL CasMab; human IgG1 version of PcMab-6 FACS, ADCC/CDC done zenogen
anti-PODXL mAb
(humPcMab-6-f; human IgG1)
CasMab for PODXL; humanized mAb originated from PcMab-6 FACS humPcMab-6-f done zenogen
anti-hPDPN mAb (humPcMab-6-scFv; scFv) CasMab; scFv originated from PcMab-6 CART in preparation done
Back to list

Company (clone) --> mAb list (target)

Abcam
AMab-6/ C44Mab-5/ CMab-43/ EMab-134/ GMab-r1/ H2Mab-139/ HMab-2/ KMab-1/ LpMab-7/ MMab-1/ MsMab-1/ PMab-1/ PcMab-47/ RcMab-1/ SMab-1/ WMab-1
Absolute antibody
PMab-1/ PMab-2/ PMab-292/ PMab-295
APRO (PFI)
AMab-6/ HMab-1/ HMab-2/ LpMab-12/ NZ-1/ PMab-1/ PMab-2/ PMab-44/ PcMab-47/ TMab-2
BD
C2Mab-6/ C3Mab-4 (C3Mab-6, C3Mab-7)/ C6Mab-9/ C39Mab-1 (C39Mab-2)/ C44Mab-6/ C44Mab-9/ CX6Mab-1/ C9Mab-1/ CMab-43/ H2Mab-303 (H2Mab-304, H2Mab-307)/ EMab-134/ EMab-300/ LpMab-17/ LpMab-23/ NZ-1/ PMab-1/ RMab-3/ TgMab-2
BioLegend
C20Mab-60/ C44Mab-5/ KrMab-3/ LpMab-21/ PMab-1/ PMab-2/ YM-2
CST
C44Mab-3/ C44Mab-9/ C44Mab-108/ KrMab-3/ LpMab-12/ RcMab-1/ RcMab-1
Exbio
C9Mab-1/ H3Mab-17/ LpMab-23/ PcMab-47/ TrMab-6
FUJIFILM WAKO
AMab-6/ EMab-134/ HMab-1/ HMab-2/ MsMab-1/ NZ-1/ NZ-1.2/ PMab-1/ PMab-2/ PMab-32/ PMab-38/ PcMab-47/ RMab-3/ RMab-22/ SMab-1/ TMab-6
Hycult
LpMab-12/ LpMab-13/ LpMab-17
IBL
HMab-1/ SMab-1
MCP
LpMab-3/ LpMab-7/ LpMab-9/ LpMab-12/ LpMab-21
MBL
GMab-r1/ HMab-1/ KMab-1/ KrMab-3/ MMab-1/ MsMab-2/ NZ-1.2/ PMab-1/ RcMab-1/ RMab-3/ SMab-1/ WMab-1
Merck
C8Mab-2/ C44Mab-3/ C44Mab-9/ C44Mab-108/ EpMab-16/ G4B1/ HMab-1/ LpMab-12/ LpMab-13/ LpMab-17/ LpMab-21/ MsMab-1/ NZ-1.2/ PMab-1/ PMab-2/ RMab-3/ RMab-22/ SMab-1/ t8E4/ TpMab-3/ TrMab-29/ TwMab-1
Novus
NZ-1.2/ PMab-1
Zenogen
LpMab-7/ LpMab-12/ PMab-38/ PMab-44/ PMab-48/ PMab-52/ PMab-202/ PMab-210/ PMab-213/ PMab-219/ PMab-225/ PMab-231/ PMab-233/ PMab-235/ PMab-237/ PMab-247/ PMab-256/ NZ-1.2
Back to list